December 6–10, 2011

San Antonio Texas USA program

www.sabcs.org
Dear Colleague,

The UT Health Science Center San Antonio, Baylor College of Medicine and The American Association for Cancer Research take
great pride in presenting the 2011 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) which will take place December
6-10, 2011, at the Henry B. Gonzalez Convention Center.
SABCS continues to be the premier conference for basic, translational and clinical cancer research professionals to present and
discuss the latest breast cancer data from all over the world.
Two special reports in this year’s program are of particular interest: Wednesday, December 7, Breast Cancer and the Environment:
A Life Course Perspective—Report Release from an IOM Committee; Saturday, December 10, Genome Data for the Masses:
Presentation of TCGA and IGC Breast Tumor Data.
New this year is a special section for ongoing clinical trials posters. These posters highlight ongoing trials which have not yet been
concluded. It’s a great opportunity for trialists to consider trials they might join and/or take into consideration in the design of
the next generation of trials.
Attendance at our highly popular educational sessions continued to grow in 2010, so in 2011 they have been moved to larger
rooms in the convention center in order to seat everyone.
The Year in Review will again be presented on our final day. This compilation and contextualization of the year’s most important
breast cancer science, presented by leading authorities, has become a “can’t miss” event. Be sure to plan your travel so that you
can attend!
During lunch we continue to present opportunities for discussion of case studies and also discussions of advances in the basic
sciences.
We are sure you will find this symposium to be an excellent forum for state-of-the-art information on breast cancer, with an
international audience of academic and private physicians and researchers. We hope that you will be able to attend.

Sincerely,

Peter M. Ravdin, MD, PhD C. Kent Osborne, MD Carlos L. Arteaga, MD

Director, Breast Cancer Program Professor of Medicine and Molecular Professor of Medicine and Cancer Biology
Cancer Therapy & Research Center and Cellular Biology Interim Director,
at UTHSCSA Director, Dan L. Duncan Cancer Center Division of Hematology-Oncology
San Antonio, Texas Director, Breast Center Director, Breast Cancer Program
Baylor College of Medicine Vanderbilt-Ingram Cancer Center
Houston, Texas Vanderbilt University
Nashville, Tennessee
 table of contents

Abstracts Online . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Registration Contact Form, Group . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24

Accreditation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Registration, Exhibitor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Badges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Registration Form, Career Development Forum . . . . . . . . . . . . . . . . 30
Climate & Comfort . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Registration Form, Advance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Committees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 Registration Form, Press/Media . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Exhibit Hours . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Registration Highlights . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Inside Back Cover Registration Hours . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Food & Beverage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Registration Instructions, General . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
History . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Registration Instructions, Group . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Hotel Rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 Registration On Site . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Hotel Map & Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 Registration, Press/Media . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Housing Instructions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 Registration, Spouse/Guest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Housing Request Form . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 San Antonio Sights . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Important Dates 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Schedule At A Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Information Boards . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Slide Viewer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Internet Café . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Special Assistance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Literature Displays . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Supporters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Inside Back Cover
Location . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Symposium Contact Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Mobile App . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Symposium Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12–15
Posters Online . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Symposium Objective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2–10 Transportation, Ground . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Proof of Attendance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Webcast. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Registration Cancellations & Refunds . . . . . . . . . . . . . . . . . . . . . . . . . . 14

Meeting Site
Henry B. Gonzalez Convention Center
200 E. Market Street, San Antonio, TX 78205
 schedule at a glance

Program
Tuesday 12/6/11 Wednesday 12/7/11 Thursday 12/8/11 Friday 12/9/11 Saturday 12/10/11
Slots

7:00
7:15 Career
7:30 Development Poster Session 2 Poster Session 4
7:45 Forum
8:00 6:45-8:15 Poster Disc 3 Poster Disc 7
8:15 Poster Disc 4 Poster Disc 8
8:30 Welcome
8:45 Plenary Lecture Special Report
9:00 Endo Rx - Winer Plenary Lecture Plenary Lecture Genomic Data
9:15 Macrophag-Coussens Axillary Surg - Smith
9:30
9:45
10:00
10:15 General General
Session 1 Session 3 General Year in Review
10:30 Session 5 Lectures
10:45 Basics - Polyak
11:00 Transl - Richardson
11:15 Early - Davidson
11:30 McGuire Lecture
AACR Lecture Gray AACR Young Inv Late - Rugo
11:45 Brugge Parsons
Registration 12:00
12 Noon - 7:30 pm 12:15 Lunch Lunch Lunch
12:30 12:00-1:35 12:00-1:35 12:00-1:35
12:45 Forums12:30-1:35 Forums12:30-1:35 Forums12:30-1:35
Educational 1:00
Sessions 1 Basic(B) – Initiation Basic(B) – ER Basic(B) – Microenv
1:15 Clin(A) – Cost of Care Clin(A) – Case Disc Clin(A) – Case Disc
2:00 - 3:30 pm 1:30
Rx Metastatic 1:45 Special Report
Mouse Models 2:00 IOM: Environ/BC Mini Symp 1 (B) Mini Symp 3 (B)
2:15 Heterogeneity/Met Metabolomics
2:30 Mini Symp 2 (D) Mini Symp 4 (D)
Educational 2:45 Environ Exposures Neoadjuvant Rx
Sessions 2 3:00 General
4:00 - 5:30 pm Session 2
3:15
Early Breast Ca 3:30
Biomarker Discovery 3:45
Trials Devel Countries General General
4:00 Session 4 Session 6
4:15 Komen Brinker
Lectures
4:30 Arteaga and Giuliano
Educational 4:45
Sessions 3 5:00
6:00 - 7:30 pm 5:15 Poster Session 1 Poster Session 3 Poster Session 5
Rx Special Pop 5:30
Good Target? 5:45 Poster Disc 1 Poster Disc 5 Poster Disc 9
Reconstruction 6:00 Poster Disc 2 Poster Disc 6 Poster Disc 10
6:15
6:30 Ongoing Trials 1 Ongoing Trials 2 Ongoing Trials 3
6:45
7:00

For Exhibit Hours See Page 12

1
 program

2011 CTRC-AACR San Antonio Controversies in early breast cancer: Small tumors
Peter M. Ravdin, MD, PhD
Breast Cancer Symposium UT Health Science Center San Antonio
San Antonio, TX
Program Schedule Chemotherapy benefit in ER positive breast cancer — Mixed
messages
(AT PRESS TIME)
Kathy Albain, MD, FACP
Refer to www.sabcs.org for the most current information. Loyola University Chicago Stritch School of Medicine
Maywood, IL
Room Locations
Adjuvant therapy in patients with a borderline HER-2 status
Exhibit Halls A, B, C & D: Street Level Angelo Di Leo, MD, PhD
Ballrooms A & B: Street Level Hospital of Prato
Bridge Hall: Street Level Prato, ITALY
4:00-5:30 New Technologies in Biomarker Discovery for the Clinician –
Ballroom A
Tuesday, December 6, 2011 Moderator: Trey Westbrook, PhD
Baylor College of Medicine
12:00-7:30 REGISTRATION – Bridge Hall Houston, TX
Pre-registered attendees can obtain materials. Those who have not yet Metabolomics as a tool to study cancer progression
registered may do so. Arun Sreekumar, PhD
2:00-7:30
Educational Sessions – Baylor College of Medicine
Street Level – Ballrooms A & B and Houston, TX
Exhibit Hall D Proteomics
An update on advances in the technologies available for translational Gordon Mills, MD, PhD
research. Sessions are to provide people with a better understanding of UT MD Anderson Cancer Center
the talks they hear using the techniques described. They also provide Houston, TX
researchers with a guide to the techniques they should be considering TBA
for their studies. Stephen Baylin, MD
2:00-3:30 Treatment of Metastatic Breast Cancer – Breast Cancer as a Johns Hopkins University
Chronic Disease – Ballroom A Baltimore, MD
Moderator: TBA 4:00-5:30 Breast Cancer Trials in Developing Countries – Opportunities and
Management of ER positive Challenges – Ballroom B
TBA Moderator: Ismail Jatoi, MD, PhD, FACS
UT Health Science Center San Antonio
ER negative San Antonio, TX
Vered Stearns, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Challenges in the design and implementation of breast cancer
Baltimore, MD clinical trials in developing countries
Sudeep Gupta, MD, DM
HER2 positive Tata Memorial Hospital
Ian E. Krop, MD, PhD Mumbai, INDIA
Dana-Farber Cancer Institute
Boston, MA TBA
Sandra J. Horning, MD
2:00-3:30 Mouse Models of PI3K-Dependent and Basal-Like Breast Cancer – Genentech, Inc.
Ballroom B San Francisco, CA
Moderator: Carlos L. Arteaga, MD
Vanderbilt-Ingram Cancer Center Novel approach to breast cancer in low income countries
Vanderbilt University David J. Kerr, CBE, MA, MD, DSc FRCP (Glas & Lon), FRCGP (Hon),
Nashville, TN FMedSci
University of Oxford
TBA Oxford, UNITED KINGDOM
Ramon Parsons, MD, PhD
Institute for Cancer Genetics 6:00-7:30 Challenges in the Care of Special Populations with Breast Cancer –
Columbia University Exhibit Hall D
New York, NY Moderator: Mothaffar Rimawi, MD
Baylor College of Medicine
Mouse models of basal-like breast cancer Houston, TX
Jos Jonkers, PhD
Netherlands Cancer Institute Oncofertility: Translation in multidimensions
Amsterdam, NETHERLANDS Teresa K. Woodruff, PhD
Northwestern University
TBA Chicago, IL
Michael T. Lewis, PhD, BS
Baylor College of Medicine Treatment of young women with breast cancer
Houston, TX Ann H. Partridge, MD, MPH
Dana-Farber Cancer Institute
4:00-5:30 Controversies in Early Breast Cancer – Exhibit Hall D Boston, MA
Moderator: Peter M. Ravdin, MD, PhD
UT Health Science Center San Antonio
San Antonio, TX
2
 program

Treatment of older women with breast cancer 6. Grant Writing – Clinical/Translational

Arti Hurria, MD Lisa A. Carey, University of North Carolina Lineberger Comprehensive
City of Hope Cancer Center, Chapel Hill, NC
Duarte, CA 7. Grant Writing – Basic/Translational
6:00-7:30 What Makes a Good Target? – Ballroom A Joan S. Brugge, Harvard Medical School, Boston, MA
Moderator: Mark D. Pegram, MD 8. How to Become a Clinical Trialist
Miller School of Medicine of University of Miami Hope S. Rugo, UCSF Helen Diller Family Comprehensive Cancer
Miami, FL Center, San Francisco, CA
9. How to Get the Most Out of your Fellowship Years – Translational
TBA Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA
Stephen W. Fesik, PhD 10. How to Get the Most Out of your Fellowship Years – Clinical
Vanderbilt University Medical Center Nancy U. Lin, Dana-Farber Cancer Institute, Boston, MA
Nashville, TN 11. How to Get the Most Out of your Predoctoral Experience
TBA Rong Li, University of Texas Health Science Center, San Antonio, TX
Mark D. Pegram, MD 12. Leadership Skills
Miller School of Medicine of University of Miami Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN
Miami, FL 13. Making the Transition to Independence
Nancy E. Davidson, University of Pittsburgh Cancer Institute,
TBA Pittsburgh, PA
Steve Shak, MD 14. Making the Transition to Independence
Genomic Health, Inc Valerie M. Weaver, University of California San Francisco Medical
Hillsborough, CA Center, San Francisco, CA
6:00-7:30 Reconstruction – Ballroom B 15. Making the Transition to Independence
Moderator: Richard L. Crownover, MD, PhD Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA
Cancer Therapy and Research Center at 16. Mentoring and Supervising
UT Health Science Center San Antonio Douglas Yee, University of Minnesota Masonic Cancer Center,
San Antonio, TX Minneapolis, MN
17. Negotiating a Job Offer
Breast reconstruction with implants and post-mastectomy Matthew J. Ellis, Washington University Siteman Cancer Center,
irradiation: algorithms and outcomes St. Louis, MO
Peter G. Cordeiro, MD, FACS 18. Publication Strategies
Memorial Sloan-Kettering Cancer Center Jose Baselga, Massachusetts General Hospital Cancer Center,
New York, NY Boston, MA
TBA 19. Tenure and Promotion
Richard C. Zellars, MD Suzanne A.W. Fuqua, Baylor College of Medicine Cancer Center,
Johns Hopkins University Houston, TX
Baltimore, MD Additional topics and mentors to be announced (see www.sabcs.org
for updates).
Measuring outcomes in breast reconstruction: The patient
perspective 8:30-8:45 WELCOME – Exhibit Hall D
Andrea L. Pusic, MD, MHS, FRCSC
Memorial Sloan-Kettering Cancer Center Opening Remarks
New York, NY 8:45-9:15 PLENARY LECTURE 1 – Exhibit Hall D
TBA
Wednesday, December 7, 2011 Eric P. Winer, MD
Dana-Farber Cancer Institute
6:45-8:15 Career Development Forum: A Networking Session Boston, MA
for Young Investigators – Ballroom B
9:15-11:30 GENERAL SESSION 1 – Exhibit Hall D
Networking and career development opportunities for early-
career scientists. The session is open to early-career scientists, defined 9:15 S1-1. A Phase III randomized trial of Anastrozole versus
as graduate students, postdoctoral or clinical fellows, or medical Anastrozole and Fulvestrant as first-line therapy for
students and residents, who are registered attendees of the SABCS postmenopausal women with metastatic breast cancer: SWOG
S0226
Space in the workshop is limited to 200 participants; registrations will Mehta RS, Barlow WE, Albain KS, Vandenberg T, Dakhil SR, Tirumali NR,
be accepted on a first-come, first-served basis and is free of charge. Lew DL, Hayes DF, Gralow JR, Livingston RB, Hortobagyi GN. University
Please complete the registration form on page 30. of California at Irvine, Chao Family CCC, Orange, CA; SWOG, Seattle,
WA; Loyola University Chicago Stritch School of Medicine, Maywood, IL;
Discussion topics include London Regional Cancer Program, London, ON, Canada; Wichita CCOP,
1. Balancing Research and Clinical Practice Wichita, KS; NW Permanente, Portland, OR; University of Michigan,
Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA Michigan; Seattle Cancer Care Alliance, Seattle, WA; Arizona Cancer
2. Balancing Research and Clinical Practice Center, Tucson, AZ; University of Texas/MD Anderson Cancer Center,
Judy E. Garber, Dana-Farber Cancer Institute, Boston, MA Houston, TX.
3. Careers in Industry
Malte Peters, Novartis, Basel, Switzerland
4. Careers in Industry
Steven Shak, Genomic Health, Inc., Redwood City, CA
5. Careers in Translational Research
Rachel Schiff, Baylor College of Medicine, Houston, TX

3
 program

9:30 S1-2. Long-term follow-up in ABCSG-12: Significantly improved 12:00-1:35 Lunch

overall survival with adjuvant Zoledronic Acid in premenopausal
12:15 Product Theatre
patients with endocrine-receptor—positive early breast cancer
Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Stoeger H, Dubsky Updates in Breast Cancer in Diagnostic Testing
P, Jakesz R, Singer C, Eidtmann H, Fesl C, Eiermann W, Marth C, Greil Sponsored by Clarient, A GE Healthcare Company
R. Medical University of Vienna, Vienna, Austria; Paracelsus Medical 12:30-1:35 Clinical Science Forum – Ballroom A
University Salzburg, Salzburg, Austria; Medical University of Graz, Graz,
Austria; University of Schleswig-Holstein, Kiel, Germany; Austrian Breast Medical Economics – The Cost of Care
and Colorectal Cancer Study Group, Vienna, Austria; Red Cross Women’s Moderator: Eric P. Winer, MD
Hospital, Munich, Germany; Medical University of Innsbruck, Innsbruck, Dana-Farber Cancer Institute
Austria. Boston, MA
9:45 S1-3. Long-term survival outcomes among postmenopausal
The cost of cancer care: How much do we spend and how can
women with hormone receptor-positive early breast cancer we spend it better?
receiving adjuvant Letrozole and Zoledronic Acid: 5-year follow- Elena Elkin, PhD
up of ZO-FAST Memorial Sloan-Kettering Cancer Center
de Boer R, Bundred N, Eidtmann H, Neven P, von Minckwitz G, Martin New York, NY
N, Modi A, Coleman R. Royal Melbourne Hospital, Victoria, Australia;
Health care reform and cost control: Practical and ethical
University Hospital of South Manchester NHS Foundation Trust, considerations for cancer care providers
Manchester, United Kingdom; University Frauenklinik, Kiel, Germany; Michael Hassett, MD, MPH
UZ Gasthuisberg, Leuven, Belgium; German Breast Group, Frankfurt, Dana-Farber Cancer Institute
Germany; Novartis Oncology, East Hanover, NJ; University of Sheffield, Boston, MA
Sheffield, United Kingdom.
Panel Discussion

10:00 Discussant Eric P. Winer, MD
10:15 S1-4. Retrospective analysis of study EGF30008 by mass- Dana-Farber Cancer Institute
spectrometry based serum assay (VeriStrat®) Boston, MA
Roder J, Roder H, Hunsucker S, Grigorieva J, Ellis C, Florance A, Gagnon Michael Hassett, MD, MPH
R, O’Rourke L, Johnston S. Biodesix Inc., Aurora, CO; GlaxoSmithKline, Dana-Farber Cancer Institute
Collegeville, PA; Royal Marsden Hospital, London, United Kingdom. Boston, MA
10:30 S1-5. Modulation of cancer and stem cell biomarkers by the notch Elena Elkin, PhD
inhibitor MK-0752 added to endocrine therapy for early stage Memorial Sloan-Kettering Cancer Center
ER+ breast cancer New York, NY
Albain KS, Czerlanis C, Zlobin A, Covington KR, Rajan P, Godellas C,
Bova D, Lo SS, Robinson P, Sarker S, Gaynor ER, Cooper R, Aranha G, 12:30-1:35 Basic Science Forum – Ballroom B
Czaplicki K, Busby B, Rizzo P, Demuth T, Stiff P, Fuqua SAW, Miele L. Breast Cancer Initiation
Loyola University Chicago Cardinal Bernardin Cancer Center, Maywood, Moderator: Yi Li, PhD, MS
IL; Baylor Breast Center, Houston, TX; Merck Oncology, North Wales, PA; Baylor College of Medicine
University of Mississippi Cancer Institute, Jackson, MS. Houston, TX
10:45 S1-6. Characterization of breast cancer distant metastasis
p53, stem cells, and breast cancer
based on outcome over time using a gene expression profiling Geoffrey M. Wahl, PhD
approach and identification of pathway activities of late relapse Salk Institute for Biological Studies
Saghatchian M, Mittempergher L, Michiels S, Casinius S, Glas A, Lazar La Jolla, CA
V, Roepman P, Dessen P, Benz S, Piccart M, Delaloge S, van’t Veer L.
Institut Gustave Roussy, Villejuif, France; Netherlands Cancer Institute.,
Stem and progenitor cells and breast cancer heterogeneity
Amsterdam, Netherlands; Institut Jules Bordet, Belgium; Agendia; UCSF; Matthew Smalley, PhD
UCSC. Breakthrough Breast Cancer Centre
Institute of Cancer Research
11:00 S1-7. Molecular tumor characteristics influence adjuvant London, UNITED KINGDOM
endocrine treatment outcome
Bianchini G, Pusztai L, Iwamoto T, Kelly CM, Zambetti M, Fasolo A, Del 1:45-2:15 SPECIAL REPORT – Exhibit Hall D
Conte G, Santarpia L, Symmans WF, Gianni L. San Raffaele Cancer Breast Cancer and the Environment: A Life Course Perspective —
Center, Milan, Italy; University of Texas, MD Anderson Cancer Center, Report Release from an IOM Committee
Houston, TX; Mater Misericordiae University Hospital, Dublin, Ireland; Moderator: Amelie G. Ramirez, Dr. PH, MPH
Hospital of Prato and Istituto Toscana Tumori, Prato, Italy. UT Health Science Center
11:15 S1-8. Molecular signaling distinguishes early ER positive breast San Antonio, TX
cancer recurrences despite adjuvant Tamoxifen Irva Hertz-Picciotto, PhD, MPH
Liu MC, Dixon JM, Xuan JJ, Riggins RB, Chen L, Wang C, Cho Y, Zhu Y, University of California, Davis
Jin L, Zwart A, Wang M, Klimach UM, Wang YJ, Renshaw L, Larionov A, Davis, CA
Miller W, Clarke R. Georgetown University Lombardi Comprehensive and
Cancer Center, Washington, DC; Western General Hospital, University of Robert A. Hiatt, MD, PhD
Edinburgh, Edinburgh, Scotland, United Kingdom; Virginia Polytechnic University of California, San Francisco
Institute and State University, Arlington, VA. San Francisco, CA
11:30-12:00 AACR Distinguished Lectureship in 2:15-4:00 GENERAL SESSION 2 – Exhibit Hall D
Breast Cancer Research – Exhibit Hall D
2:15 S2-1. Partial breast brachytherapy is associated with inferior
Protective Adaptive Responses to Breast Cancer Therapies effectiveness and increased toxicity compared with whole breast
Joan S. Brugge, PhD irradiation in older patients
Harvard Medical School Smith GL, Xu Y, Buchholz TA, Giordano SH, Smith BD. University of
Boston, MA Texas M.D. Anderson Cancer Center, Houston, TX.

4
 program

2:30 S2-2. Luminal A subtype predicts radiation response in patients The Clinical Research award is presented to a clinician who has
with T1N0 breast cancer enrolled in a randomized trial of significantly furthered the identification of new prevention, detection or
Tamoxifen with or without breast radiation treatment approaches for breast cancer and its translation into clinical
Fyles A, McCready D, Pintilie M, Shi W, Done S, Miller N, Olivotto I, Weir care. This year the award is being presented to:
L, Liu F-F. Princess Margaret Hospital, Toronto, Canada; British Columbia
Cancer Agency, Vancouver, Canada. Armando E. Giuliano, MD, FACS, FRCSEd
Cedars-Sinai Medical Center
2:45 S2-3. NSABP protocol B-34: A clinical trial comparing adjuvant Saul and Joyce Brandman Breast Center
Clodronate vs. placebo in early stage breast cancer patients Los Angeles, CA
receiving systemic chemotherapy and/or Tamoxifen or no Lecture Topic: Changes in the Management of the Axilla in
therapy — final analysis Breast Cancer
Paterson AHG, Anderson SJ, Lembersky BC, Fehrenbacher L, Falkson
CI, King KM, Weir LM, Brufsky AM, Dakhil S, Lad T, Baez-Diaz L, Gralow 5:00-7:00 Poster Discussion I: Endocrine Resistance &
JR, Robidoux A, Perez EA, Zheng P, Geyer CE, Swain SM, Costantino RECEPTION – Ballroom A
JP, Mamounas EP, Wolmark N. National Surgical Adjuvant Breast Suzanne A.W. Fuqua, PhD, Discussant
and Bowel Project (NSABP); Tom Baker Cancer Centre; University of Baylor College of Medicine
Pittsburgh Graduate School of Public Health; University of Pittsburgh Houston, TX
Cancer Institute School of Medicine; Kaiser Permanente, Northern
5:00-7:00 Poster Discussion II: Local Therapy &
California; University of Alabama at Birmingham/ECOG; Cross Cancer
RECEPTION – Ballroom B
Institute; British Columbia Cancer Agency; University of Pittsburgh/
Magee Women’s Hospital; Cancer Center of Kansas; Stroger Hospital Richard Crownover, MD, PhD, Co-Discussant
Cook County MBCCOP; San Juan MBCCOP; University of Washington/ UT Health Science Center
SWOG; Centre hospitalier de l’Université de Montréal; Mayo Clinic San Antonio, TX
Jacksonville/NCCTG; Allegheny General Hospital; Washington Cancer &
Institute, Washington Hospital Center; Aultman Health Foundation. Ismail Jatoi, MD, PhD, FACS, Co-Discussant
UT Health Science Center
3:00 S2-4. Gain (German Adjuvant Intergroup Node Positive) study: A
San Antonio, TX
phase-III multicenter trial to compare dose dense, dose intense
ETC (iddETC) vs. EC-TX and Ibandronate vs. observation in 5:00-7:00 POSTER SESSION 1 & RECEPTION – Exhibit Halls A-B
patients with node-positive primary breast cancer — 1st Interim
Tumor Cell Biology
EFFICACY analysis
Immunology and Preclinical Immunotherapy P1-01
Mõbus V, Thomssen C, Harbeck N, Untch M, Jackisch C, Diel IJ, Elling
Epithelial-Mesenchymal Transition P1-02
D, Conrad B, Schneeweiss A, Kreienberg R, Huober J, Mùller V, Lùck
Microenvironment -
H-J, Bauerfeind I, Loibl S, Nekljudova V, von Minckwitz G. Städtische
Stromal-Epithelial Interactions P1-03
Kliniken Frankfurt-Hõchst, Frankfurt; Klinik und Poliklinik fùr Gynäkologie,
Stem/Progenitor Cells P1-04
Universität Halle-Wittenberg, Halle; Brustzentrum, Universitätsklinikum,
Epigenetics P1-05
Kõln; Helios-Klinikum Berlin-Buch, Berlin; Städtische Kliniken Offenbach,
Offenbach; Schwerpunktpraxis Gynäkologische Onkologie, Mannheim; Prognosis/Response Predictions
SANA Klinikum, Berlin; Elisabeth-Krankenhaus, Kassel; Universitäts- Response Predictions – I P1-06
Frauenklinik, Heidelberg; Universitäts-Frauenklinik, Ulm; Universitäts- Biomarkers – Methods P1-07
Frauenklinik, Tübingen; University Medical Center, Hamburg-Eppendorf; Epidemiology, Risk, and Prevention
Gynäkologisch-onkologische Praxis, Hannover; Frauenklinik, Landshut; Epidemiology - Population Studies P1-08
German Breast Group, Neu-Isenburg. Epidemiology - Genetic and Molecular P1-09
3:15 S2-5. Title Withheld Psychosocial, Quality of Life, and Educational Aspects
3:30 S2-6. ErbB3 expression is required for maintenance of normal and Cost-Effectiveness P1-10
transformed luminal breast epithelial cells Disparities and Barriers to Care P1-11
Cook RS, Balko JM, Rinehart C, Miller TW, Polyak K, Prat A, Perou CM, Treatment - Therapeutic Strategies
Arteaga CL. Vanderbilt University; UNC Lineberger Comprehensive HER2-Targeted Therapy P1-12
Cancer Center; Dana Farber Cancer Institute. Immunotherapy P1-13
3:45 S2-7 Mechanisms of action and biological significance of HER2 Antiangiogenic Therapy P1-14
mutations in HER2-overexpressing breast cancer Alternative Therapies P1-15
Boulbes DR, Jin Q, Arold ST, Ladbury JE, Yu D, Esteva FJ. University of Treatments - Advanced Disease
Texas - MD Anderson Cancer Center, Houston, TX; Myriad Genetics, Salt Advanced Therapy – Endocrine P1-16
Lake City, UT. Advanced Therapy – Targeted P1-17
4:00-5:00 SUSAN G. KOMEN FOR THE CURE® BRINKER AWARDS Advanced Therapy – Other P1-18
FOR SCIENTIFIC DISTINCTION LECTURES – 5:00-7:00 POSTER SESSION ONGOING TRIALS 1 – Exhibit Halls A-B
Exhibit Hall D
Bone OT1-01-01
The Basic Science award is presented to a researcher who has Her2 OT1-02-01
added substantively to our understanding of the basic biology of, or Prognostic and Predictive Markers OT1-03-01
development of, methodologies that further our ability to unravel the
genetic and molecular basis of breast cancer. This year the award is
being presented to:
Carlos L. Arteaga, MD
Vanderbilt-Ingram Cancer Center
Vanderbilt University
Nashville, TN
Lecture Topic: Oncogenes & ER: A convenient marriage for hormone-
dependent breast cancer

5
 program

9:45 S3-2. Neoadjuvant chemotherapy adapted by interim response

Thursday, December 8, 2011 improves overall survival of primary breast cancer patients —
results of the GeparTrio Trial
7:00-9:00 Poster Discussion III: Genomics & CONTINENTAL von Minckwitz G, Blohmer JU, Costa S, Denkert C, Eidtmann H, Eiermann
BREAKFAST – Ballroom A W, Gerber B, Hanusch C, Hilfrich J, Huober J, Jackisch C, Kaufmann M,
Laura J. van’t Veer, PhD, Discussant Kùmmel S, Paepke S, Schneeweiss A, Untch M, Zahm DM, Mehta K, Loibl
University of California San Francisco S. German Breast Group, Neu-Isenburg; St. Gertrauden Krankenhaus,
San Francisco, CA Berlin; Universitäts-Frauenklinik, Magdeburg; Charité, Berlin; Universitäts-
Frauenklinik, Kiel; Frauenklinik vom Roten Kreuz, Mùnchen; Universitäts-
7:00-9:00 Poster Discussion IV: Survivorship & CONTINENTAL
Frauenklinik, Rostock; Henrietten-Stiftung, Hannover; Brustzentrum
BREAKFAST – Ballroom B
Kantonsspital St. Gallen / Universitäts-Frauenklinik Tübingen;
Dawn Hershman, MD, MS, Discussant Frauenklinik, Klinikum, Offenbach; Universitäts-Frauenklinik, Frankfurt;
Columbia University Medical Center Klinikum Essen Mitte, Essen; Universitäts-Frauenklinik Rechts der Isar,
New York, NY München; Universitäts-Frauenklinik, Heidelberg; Frauenklinik, Berlin;
Brustzentrum SRH Waldkliniken, Gera.
7:00-9:00 POSTER SESSION 2 & CONTINENTAL BREAKFAST –
Exhibit Halls A-B 10:00 S3-3. Association of PTEN loss and PIK3CA mutations on outcome
in HER2+ metastatic breast cancer patients treated with first-line
Tumor Cell Biology
Lapatinib plus Paclitaxel or Paclitaxel alone
Tumor Progression, Invasion, and Metastasis P2-01
Xu B-h, Guan Z-z, Shen Z-z, Tong Z-s, Jiang Z-f, Yang J-I, DeSilvio
Oncogenes/Tumor Suppressor Genes P2-02
M, Leigh M, Ellis C. Cancer Hospital, CAMS & PUMC; Sun Yat-Sen
Growth Factors P2-03
Medical University Cancer Center; Shanghai Cancer Center, Fudan
Apoptosis and Senescence P2-04
University; Tianjin Medical University Cancer Institute and Hospital;
Angiogenesis P2-05
Hospital Affiliated to Military Medical Science; Beijing 301 PLA Hospital;
Genetics - Somatic Changes P2-06
GlaxoSmithKline.
Genetics - Germline Changes P2-07
10:15 S3-4. ER downregulation with Fulvestrant in combination with
Detection and Diagnosis - Imaging and Screening
pan-PI3K inhibitor BKM120 synergizes against ER+/PI3K-mutant
Breast Imaging – MRI P2-08
breast cancer xenografts in vivo
Molecular, Functional, and Novel Imaging P2-09
Miller TW, Fox EM, Balko JM, Meszoely IM, Sanders ME, Kuba MG,
Breast Imaging - Other Methods P2-10
Wagle N, Garraway LA, Maira S-M, Arteaga CL. Vanderbilt University,
Prognosis/Response Predictions Nashville, TN; Dana-Farber Cancer Institute, Boston, MA; Novartis Inst. for
Prognostic Factors and Biomarkers – Preclinical P2-11 Biomedical Research, Basel, Switzerland.
Prognostic Factors and Biomarkers - Clinical – I P2-12
10:30 S3-5. Next generation sequencing reveals co-activating events in
Epidemiology, Risk, and Prevention the MAPK and P13K/AKT pathways in metastatic triple negative
Familial Breast Cancer -- Genetic Testing P2-13 breast cancers
Ethnic/Racial Aspects P2-14 O’Shaughnessy J, Craig DW, Kiefer J, Sinari S, Moses TM, Wong S, Aldrich
Treatment – Local J, Christoforides A, Dinh J, Itzatt T, Blum J, Kurdoglu A, Salhia B, Baker A,
Surgery P2-15 Siddiqui A, Hoang L, Billings P, Trent JM, Mousses S, Von Hoff D, Carpten
Reconstruction P2-16 JD. Baylor Sammons Cancer Center, Dallas, TX; Translational Genomics
Research Institute, Phoenix, AZ; Life Technologies, Carlsbad, CA; US
Treatment - Adjuvant Oncology, The Woodlands, TX.
Adjuvant Endocrine Therapy P2-17
Adjuvant Therapy – Targeted P2-18 10:45 S3-6. Neoadjuvant chemotherapy of Paclitaxel with or without
Adjuvant Therapy – Other P2-19 Rad001: results of the non-responder part of the GEPARQUINTO
Study (GBG 44)
9:00-9:30 PLENARY LECTURE 2 – Exhibit Hall D Huober J, Hanusch C, Fasching PA, Rezai M, Eidtmann H, Kittel K,
Schwedler K, Tesch H, Hõß C, Mau C, Khandan F, Krabisch P, Loibl S,
Macrophages as Novel Targets for Therapy in Breast Cancer
Nekljudova V, Untch M, von Minckwitz G. Kantonsspital St. Gallen/
Lisa M. Coussens, PhD
Universitäts-Frauenklinik Tùbingen; Frauenklinik vom Roten Kreuz,
University of California San Francisco
Mùnchen; Universitäts-Frauenklinik, Erlangen.
San Francisco, CA
11:00 S3-7. TBA.
9:30-11:30 GENERAL SESSION 3 – Exhibit Hall D
11:15-12:00 William L. McGuire Memorial Lecture – Exhibit Hall D
9:30 S3-1. Update of international breast cancer study group trial
23-01 to compare axillary dissection versus no axillary dissection TBA
in patients with clinically node negative breast cancer and Joe Gray, PhD
micrometastases in the sentinel node OHSU
Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Portland, OR
Chifu C, Sargenti M, Intra M, Gentilini O, Massarut S, Garbay J-R, Zgajnar
12:00-1:35 LUNCH
J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Price KN, Goldhirsch
A, Gelber RD, Veronesi U. International Breast Cancer Study Group Trial 12:15 Product Theatre
23-01 Investigators. Abraxane
Sponsored by Celgene Corporation
12:30-1:35 CASE DISCUSSION 1 – Ballroom A
12:30-1:35 Basic Science Forum – Ballroom B
Estrogen Receptor
Moderator: Suzanne A.W. Fuqua, PhD
Baylor College of Medicine
Houston, TX

6
 program

TBA 4:00 S4-3. Prospective comparison of risk assessment tools in early
Myles A. Brown, MD breast cancer (recurrence score, uPA/PAI-1, central grade, and
Dana-Farber Cancer Institute luminal subtypes): Final correlation analysis from the phase III
Boston, MA WSG-plan B trial
Gluz O, Kreipe H, Degenhardt T, Kates R, Christgen M, Liedtke C, Shak

tba
S, Clemens M, Markmann S, Uleer C, Augustin D, Thomssen C, Nitz U,
Bert W. O’Malley, MD
Harbeck N. West German Study Group, Moenchengladbach, Germany;
Baylor College of Medicine
Medizinische Hochschule, Hannover, Germany; University of Muenster,
Houston, TX
Muenster, Germany; Genomic Health Inc, Redwood City; Klinikum
1:45-3:15 MINI-SYMPOSIUM 1 – Ballroom B Mutterhaus, Trier, Germany; Klinikum Suedstadt, Rostock, Germany;
Tumor Heterogeneity and Metastasis Gynecology Practice, Hildesheim, Germany; Klinikum Deggendorf;
Moderator: Rachel Schiff, PhD Deggendorf, Germany, University of Halle/Saale, Halle/Saale, Germany;
Baylor College of Medicine Bethesda Clinics, Moenchengladbach, Germany; University of Cologne,
Houston, TX Cologne, Germany.

Imaging cancer invasion and experimental therapy response:

4:15 S4-4. Clarifying the risk of breast cancer in women with atypical
How to overcome resistance niches breast lesions
Peter Friedl, MD, PhD Coopey SB, Mazzola E, Buckley JM, Sharko J, Belli AK, Kim EMH,
Radboud University Nijmegen Polufriaginof F, Parmigiani G, Garber JE, Smith BL, Gadd MA, Specht
HB Nijmegen, NETHERLANDS MC, Guidi AJ, Roche CA, Hughes KS. Massachusetts General Hospital,
Boston, MA; Dana-Farber Cancer Institute, Boston, MA; Newton-Wellesley
Tumor-entrained neutrophils inhibit breast cancer metastasis
Hospital, Newton, MA; Wayne State University, Detroit, MI.
seeding in the lung
Robert Benezra, PhD 4:30 S4-5. Comparison of PAM50 risk of recurrence (ROR) score with
Memorial Sloan-Kettering Cancer Center oncotypeDx and IHC4 for predicting residual risk of RFS and
New York, NY distant-(D)RFS after endocrine therapy: A TransATAC study
Dowsett M, Lopez-Knowles E, Sidhu K, Pineda S, Cowens JW, Ferree
TBA
S, Storhoff J, Schaper C, Cuzick J. Royal Marsden Hospital and
Matthew J. Ellis, MB, BChir, PhD Breakthrough Breast Cancer Centre, London, United Kingdom; Wolfson
Washington University School of Medicine Institute of Preventive Medicine, London, United Kingdom; Nanostring
St. Louis, MO Technologies, Seattle, WA.
1:45-3:15 MINI-SYMPOSIUM 2 – Exhibit Hall D 4:45 S4-6. A quantitative multigene RT-PCR assay for predicting
Environmental Exposures, Epigenetics, and Epidemiology recurrence risk after surgical excision alone without irradiation for
Moderator: Cheryl Lyn Walker, PhD ductal carcinoma in situ (DCIS): A prospective validation study of
UT MD Anderson Cancer Center the DCIS score from ECOG E5194
Houston, TX Solin LJ, Gray R, Baehner FL, Butler S, Badve S, Yoshizawa C, Shak S,
Hughes L, Sledge G, Davidson N, Perez EA, Ingle J, Sparano JA, Wood
TBA
W. Albert Einstein Medical Center, Philadelphia, PA; Eastern Cooperative
Michele R. Forman, PhD Oncology Group, Boston, MA; Genomic Health, Inc., Redwood City,
UT Austin CA; Indiana University, Indianapolis, IN; The Hope Center, Cartersville,
Austin, TX GA; University of Pittsburgh, Pittsburgh, PA; Mayo Clinic Jacksonville,
TBA
Jacksonville, FL; Mayo Clinic Rochester, Rochester, MN; Albert Einstein
Robert A. Hiatt, MD, PhD College of Medicine Bronx, NY; Emory University, Atlanta, GA.
University of California, San Francisco 5:00-7:00 Poster Discussion V: HER2 & Reception – Ballroom A
San Francisco, CA
Michael F. Press, MD, PhD, Discussant
TBA
USC/ Norris Comprehensive Cancer Center
Cheryl Lyn Walker, PhD Los Angeles, CA
UT MD Anderson Cancer Center
Houston, TX 5:00-7:00 Poster Discussion VI: Cost Effectiveness /
Utilization & Reception – Ballroom B
2:00 PRODUCT THEATRE
Thomas J. Smith MD FACP, Discussant
Prognostic Utility of Breast Cancer Index for Late Relapse in VCU-Massey Cancer Center
Patients with Early Stage Breast Cancer Richmond, VA
Sponsored by bioTheranostics
5:00-7:00 POSTER SESSION 3 & RECEPTION – Exhibit Halls A-B
3:15-5:00 GENERAL SESSION 4 – Exhibit Hall D
Tumor Cell Biology
3:15 S4-1. Overdiagnosis in breast cancer screening: Methodological Novel/Emerging Therapeutic Targets P3-01
considerations of current estimates New Agents and Mechanisms P3-02
Smith RA, Duffy SW. American Cancer Society, Atlanta, GA; Queen Mary Micro RNAs P3-03
University of London, London, United Kingdom. Molecular Profiles P3-04
3:30 Discussant Tumor Heterogeneity/
Molecular Subclassification P3-05
3:45 S4-2. The risk of contralateral breast cancer in BRCA1/2 carriers Genomics P3-06
compared to non-BRCA1/2 carriers in an unselected cohort
van den Broek AJ, Schmidt MK, Tollenaar RAEM, van ‘t Veer LJ, van Detection and Diagnosis
Leeuwen FE. Netherlands Cancer Institute, Amsterdam, Netherlands; Axillary Staging and Sentinel Nodes P3-07
Leiden University Medical Center, Leiden, Netherlands.

7
 program

Epidemiology, Risk, and Prevention 9:00-9:30 PLENARY LECTURE 3 – Exhibit Hall D

Prevention - Behavioral Interventions P3-08
Advances in Axillary Surgery: Sentinel Nodes and Beyond
Prevention - Nutritional Studies P3-09
Barbara L. Smith, MD, PhD
Prevention - Preclinical Studies and
Massachusetts General Hospital
Model Systems P3-10
Boston, MA
Prevention - Clinical Trials P3-11
9:30-11:30 GENERAL SESSION 5 – Exhibit Hall D
Treatment - Local
Breast Conservation P3-12 9:30 S5-1. Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Biomarker
Radiotherapy P3-13 analyses of a 4-arm randomized phase II study (NeoSphere) in
patients (pts) with HER2-positive breast cancer (BC)
Treatment - Therapeutic Strategies
Gianni L, Bianchini G, Kiermaier A, Bianchi G, Im Y-H, Pienkowski T,
Neoadjuvant Chemotherapy P3-14
Roman L, Liu M-C, Tseng L-M, Ratnayake J, Szado T, Ross GA, Valagussa P.
Neoadjuvant Endocrine Therapy P3-15
Oncologia Medica, San Raffaele Cancer Center, Milan, Italy; Roche, Basel,
New Drugs and Treatment Strategies P3-16
Switzerland; Oncologia Medica 1, Fondazione IRCCS Instituto Nazionale
Novel Drugs and Targeted Agents P3-17
Tumori, Milan, Italy; Samsung Medical Center, Seoul, Korea; Centrum
Signal Transduction Inhibitors P3-18
Onkologii, Warsaw, Poland; Leningrad Regional Oncology Dispensary,
5:00-7:00 POSTER SESSION ONGOING TRIALS 2 – Exhibit Halls A-B St Petersburg, Russian Federation; Koo Foundation Sun Yat-Sen Cancer
Center, Taipei, Taiwan; Taipei-Veterans General Hospital, National
Chemotherapy OT2-01-01
Yang-Ming University, Tiapei, Taiwan; Roche Products Limited, Welwyn,
Endocrine Therapy OT2-02-01
United Kingdom; Genentech, South San Francisco, CA; Fondazioine
Diagnosis and Biomarkers OT2-03-01
Michelangelo, Milan, Italy.
Prevention OT2-04-01
Imaging OT2-05-01 9:45 S5-2. PAM50 HER2-enriched subtype enriches for tumor response
Radiotherapy OT2-06-01 to neoadjuvant anthracyclines/Taxane and Trastuzumab/Taxane
Side-effect Control OT2-07-01 containing regimens in HER2-positive breast cancer
Cheang MCU, Prat A, Fan C, Perou CM. Lineberger Comprehensive
Cancer Center, Chapel Hill, NC.
Friday, December 9, 2011
10:00 S5-3. Basement membrane localized tumor cells are protected
7:00-9:00 Poster Discussion VII: What’s New in Chemotherapy from HER2-targeted therapy in vivo
Trials? & CONTINEnTAL BREAKFAST – Ballroom A Zoeller JJ, Bronson RT, Gilmer TM, Selfors LM, Lu Y, Mills GB, Brugge JS.
Harvard Medical School, Boston, MA; GlaxoSmithKline, Research Triangle
Clifford Hudis, MD, Discussant
Park, NC; UT MD Anderson Cancer Center, Houston, TX.
Memorial Sloan-Kettering Cancer Center
New York, NY 10:15 S5-4. pCR as a surrogate in HER2-positive patients treated with
Trastuzumab
7:00-9:00 Poster Discussion VIII: Targeting Triple NegativeS
Loibl S, von Minckwitz G, Blohmer JU, Costa S, Eidtmann H, Fasching
ET AL & CONTINEnTAL BREAKFAST – Ballroom B
PA, Gerber B, Hanusch C, Hilfrich J, Huober J, Jackisch C, Kaufmann M,
Geoffrey Lindeman, MD, PhD, Discussant Konecny G, Denkert C, Nekljudova V, Mehta K, Untch M. German Breast
Walter and Eliza Hall Institute of Medical Research Group, Neu-Isenburg; St. Gertrauden Krankenhaus, Berlin; Universitäts-
Parkville, AUSTRALIA Frauenklinik, Magdeburg; Universitätsklinikum, Kiel; University Hospital,
Erlangen; Universitäts-Frauenklinik, Rostock; Klinikum zum Roten Kreuz,
7:00-9:00 POSTER SESSION 4 & CONTINENTAL BREAKFAST–
Mùnchen; Henrietten-Stiftung, Hannover; Universitäts-Frauenklinik,
Exhibit Halls A-B
Tübingen; Städtische Kliniken, Offenbach; Universitäts-Frauenklinik,
Tumor Cell Biology Frankfurt; University of California, Los Angeles; Charité, Berlin; Helios
Endocrine Therapy and Resistance P4-01 Klinikum Berlin-Buch, Berlin.
Hormonal Factors and Receptors P4-02
10:30 S5-5. A phase III, randomized, double-blind, placebo-
Animal Models P4-03
controlled registration trial to evaluate the efficacy and safety
Mammary Development and Differentiation P4-04
of Pertuzumab + Trastuzumab + Docetaxel vs. placebo +
Metabolism and Breast Cancer P4-05
Trastuzumab + Docetaxel in patients with previously untreated
Micrometastases P4-06
HER2-positive metastatic breast cancer (CLEOPATRA)
Detection and Diagnosis – Pathology Baselga J, Kim S-B, Im S-A, Hegg R, Im Y-H, Roman L, Pedrini JL, Cortés
Circulating Tumor Cells P4-07 J, Knott A, Clark E, Ross GA, Swain SM. Massachusetts General Hospital
Circulating Markers P4-08 Cancer Center, Boston, MA; Asan Medical Center, University of Ulsan,
Prognosis/Response Predictions College of Medicine, Seoul, Korea; Seoul National University College
Prognostic Factors and Biomarkers - Clinical – II P4-09 of Medicine, Seoul, Korea; Hospital Pérola Byington, São Paulo, Brazil;
Samsung Medical Center, Sungkyunkwan University School of Medicine,
Epidemiology, Risk, and Prevention Seoul, Korea; Lenigrad Regional Oncology Dispensary, St. Petersburg,
Risk Factors and Modeling P4-10 Russian Federation; CPMEC-Mastology Unit of Conceição Hospital,
Epidemiology, Risk, and Prevention – Other P4-11 Porto Alegre, Brazil; Vall d’Hebron University Hospital, Barcelona, Spain;
Psychosocial, Quality of Life, and Educational Aspects Roche Products Limited, Welwyn, United Kingdom; Washington Cancer
Survivorship Research P4-12 Institute, Washington Hospital Center, Washington, DC.
Palliation and Pain Management P4-13
Quality of Life – Supportive Care P4-14
Psychological Aspects P4-15
Treatment - Types and Sites of Breast Cancer
Bone Metastases P4-16
Brain Metastases P4-17
DCIS/LCIS P4-18
Male Breast Cancer P4-19
Inflammatory Breast Cancer P4-20
8
 program

10:45 S5-6. Neoadjuvant Pertuzumab and Trastuzumab concurrent or HIF-1, Metabolism, and Metastasis

sequential with an Anthracycline-containing or concurrent with Gregg L. Semenza, MD, PhD
an Anthracycline-free standard regimen: A randomized phase II The Johns Hopkins University School of Medicine
study (TRYPHAENA) Baltimore, MD
Schneeweiss A, Chia S, Hickish T, Harvey V, Eniu A, Hegg R, Tausch C, Seo
TBA

J-H, Tsai Y-F, Ackrill A, Ross G, Cortés J. National Center for Tumor Diseases,
Michael Pollak, MD
University Hospital, Heidelberg, Germany; British Columbia Cancer Agency
McGill University
- Vancouver Centre, University of British Columbia, Vancouver, Canada;
Montreal, CANADA
Royal Bournemouth Hospital, Bournemouth University, Bournemouth,
United Kingdom; Auckland City Hospital, Auckland, New Zealand; Cancer 1:45-3:15 MINI-SYMPOSIUM 4 – Exhibit Hall D
Institute “I. Chiricuta”, Cluj-Napoca, Romania; Hospital Pérola Byington, The Role and Promise of Neoadjuvant Therapy in Breast Cancer
São Paulo, Brazil; Breast-Center, Zürich, Switzerland; Korea University Moderator: Lisa A. Carey, MD, ScM
Guro Hospital, Guro, Korea; Taipei Veterans General Hospital, Taipei, University of North Carolina
Taiwan; Roche Products Limited, Welwyn, United Kingdom; Vall d’Hebron Chapel Hill, NC
University Hospital, Barcelona, Spain.

TBA
11:00 S5-7. A phase 2, randomized, open-label, study of Neratinib (HKI- Lisa A. Carey, MD, ScM
272) vs Lapatinib plus Capecitabine for 2nd/3rd-line treatment of University of North Carolina
HER2+ locally advanced or metastatic breast cancer Chapel Hill, NC
Martin M, Bonneterre J, Geyer, Jr CE, Ito Y, Ro J, Lang I, Kim S-B, Germa
C, Vermette J, Vo Van ML, Wang K, Wang K, Awada A. Hospital Preoperative endocrine therapy: New approaches

Universitario Gregorio Marañón, Madrid, Spain; Centre Oscar Lambret, Ian Smith, MD
Lille, France; Allegheny Cancer Center, Pittsburgh, PA; The Cancer Royal Marsden Hospital
Institute Hospital of JFCR, Tokyo, Japan; National Cancer Center, Goyang, London, UNITED KINGDOM
Korea; National Institute of Oncology, Budapest, Hungary; Asan Medical Interface with radiation oncology

Center, Seoul, Korea; Pfizer Global Research and Development, Paris, Thomas A. Buchholz, MD
France; Pfizer Inc, Collegeville, PA; Bristol Meyers Squibb, Princeton, NJ; UT MD Anderson Cancer Center
Jules Bordet Institute, Brussels, Belgium. Houston, TX
11:15 Discussion TBA

C. Kent Osborne, Baylor College of Medicine, Houston, TX Carlos L. Arteaga, MD
11:30-12:00
AACR Outstanding Investigator Award for Breast Vanderbilt-Ingram Cancer Center
Cancer Research, funded by Susan G. Komen Vanderbilt University
for the Cure® – Exhibit Hall D Nashville, TN
TBA 3:15-5:00 GENERAL SESSION 6 – Exhibit Hall D
Ramon E. Parsons, MD, PhD 3:15 S6-1. Menopause-specific and health-related qualities of
Columbia University life among post-menopausal women taking Exemestane for
New York, NY prevention of breast cancer: Results from the NCIC CTG MAP.3
12:00-1:35 LUNCH placebo-controlled randomized controlled trial
Maunsell E, Richardson H, Ingle JN, Ales-Martinez JE, Chlebowski RT,
12:15 Product Theatre Fabian CJ, Sarto GE, Garber JE, Pujol P, Hiltz A, Tu D, Goss PE. Université
Abraxane Laval, Quebec City, QC, Canada; Queen’s University, Kingston, ON,
Sponsored by Celgene Corporation Canada; Mayo Clinic, Rochester, MN; San Sebastian De Los (GEICAM),
Madrid, Spain; Los Angeles Biomedical Research Institute, Torrance, CA;
12:30-1:35 CASE DISCUSSION 2 – Ballroom A
University of Kansas Medical Center, Westwood, KS; Center for Women’s
12:30-1:35 Basic Science Forum – Ballroom B Health and Health Research, Madison, WI; Dana Farber Cancer Institute,
Boston, MA; CHU-Hopital Arnaud de Villeneuve, Montepellier, France;
Tumor Microenvironment
Massachusetts General Hospital Cancer Center, Boston, MA.
Moderator: Rong Li, PhD
UT Health Science Center San Antonio 3:30 S6-2. Patient-reported predictors of early treatment
San Antonio, TX discontinuation: NCIC JMA.27/E1Z03 quality of life study of
postmenopausal women with primary breast cancer randomized

Forcing breast cancer risk & progression
to Exemestane or Anastrozole
Valerie M. Weaver, PhD
Wagner LI, Zhao F, Chapman J-AW, Cella D, Shepherd LE, Sledge GW,
University of California San Francisco
Goss PE. Northwestern University Feinberg School of Medicine, Chicago,
San Francisco, CA
IL; Dana-Farber Cancer Institute, Boston, MA; NCIC Clinical Trials Group,
COX-2 dependent collagen fibrillogenesis drives metastasis in
Queen’s University, Kingston, ON, Canada; Indiana University Simon
the postpartum involuting mammary gland Cancer Center, Indianapolis, IN; Massachusetts General Hospital, Boston,
Pepper J. Schedin, PhD MA.
University of Colorado Denver
3:45 Discussion
Aurora, CO
Patricia A. Ganz, MD
1:45-3:15 MINI-SYMPOSIUM 3 – Ballroom B UCLA Jonsson Comprehensive Cancer Center
Metabolism in Breast Cancer – Metabolomics Los Angeles, CA
Moderator: TBA 4:00 S6-3. Influence of hospital factors, physician factors and type

TBA of health insurance on receipt of immediate postmastectomy
Susan E. Hankinson, ScD reconstruction in young women with breast cancer
Harvard Medical School Hershman DL, Neugut AI, Richards CA, Kalinsky K, Charles AS, Wright JD.
Boston, MA Columbia University, New York, NY; Mailman School of Public Health,
New York, NY.

9
 program

4:15 S6-4. Protein kinase mutation patterns of in human breast cancer

Pusztai L, Qi Y, Shi W, Liu C-G, Wang B, Liu X, Booser D, Esteva FJ, Saturday, December 10, 2011
Symmans F, Hortobagyi GN. UT MD Anderson Cancer Center, Houston,
7:00 CONTINENTAL BREAKFAST
TX.
8:00-10:00 SPECIAL REPORT – Exhibit Hall D
4:30 S6-5. Obesity drives epithelial-to-mesenchymal transition and
tumor progression in a novel claudin-low mammary cancer model Genome Data for the Masses: Presentation of TCGA and IGC Breast
Dunlap SM, Chiao LJ, Nogueria L, Usary J, Perou CM, Varticovski L, Tumor Data
Hursting SD. University of Texas, Austin, TX; University of North Carolina, Moderators: Charles M. Perou, PhD
Chapel Hill, NC; National Cancer Institute, Bethesda, MD; University of University of North Carolina
Texas M.D. Anderson Cancer Center, Smithville, TX. Chapel Hill, NC
and
4:45 S6-6. Expression of key estrogen-regulated genes (ERGs) differ
Michael Stratton, FRCPath, FMCDSCI, FRS
substantially across the menstrual cycle in ER+ breast tumours
The Wellcome Trust Sanger Institute
Haynes BP, Viale B, A’Hern R, Smith IE, Dowsett M, Galimberti V,
Hinxton, Cambridge, UNITED KINGDOM
Rotmensz N, Gibelli B. Royal Marsden Hospital, London, United
Kingdom; Institute of Cancer Research, Sutton, Surrey, United Kingdom; TCGA breast cancer sequencing: Results and interpretation
European Institute of Oncology, Milan, Italy. Elaine R. Mardis, PhD
Washington University
5:00-7:00 Poster Discussion IX: PI3K / mTOR & Reception –
St. Louis, MO
Ballroom A
Diverse patterns of mutation in breast cancer genomes
Ana-Maria Gonzalez-Angulo, MD, MSC, Discussant
Michael Stratton, FRCPath, FMCDSCI, FRS
UT MD Anderson Cancer Center
The Wellcome Trust Sanger Institute
Houston, TX
Hinxton, Cambridge, UNITED KINGDOM
5:00-7:00 Poster Discussion X: Tumor Suppressors/DNA
Integrative genomic analyses of breast cancer from The Cancer
Repair & Reception – Ballroom B
Genome Atlas (TCGA)
Nicholas Turner, MD, Discussant Chad J. Creighton, PhD
Royal Marsden Hospital Baylor College of Medicine
London, UNITED KINGDOM Houston, TX
5:00-7:00 POSTER SESSION 5 & RECEPTION - Exhibit Halls A-B Epigenomic data analysis of TCGA breast cancer samples
Tumor Cell Biology Peter W. Laird, PhD
Biomarkers P5-01 USC Epigenome Center
Cellular Mechanisms P5-02 Los Angeles, CA
Cell Cycle Regulation P5-03 The DNA copy number landscapes and genomic architecture:
Systems Biology of Breast Cancer P5-04 Relevance for progression and outcome
Etiology/Carcinogenesis P5-05 Anne-Lise Børresen-Dale, PhD, MD (h.c.)
Drug Resistance P5-06 Oslo University Hospital
Tumor Cell and Molecular Biology – Other P5-07 Oslo, NORWAY
Detection and Diagnosis – Imaging and Screening Genomic analyzes for pathway characterization
Breast Imaging – Mammography P5-08 David Haussler, PhD
Screening P5-09 University of California, Santa Cruz
Radiology - Tumor Monitoring P5-10 Santa Cruz, CA
Detection and Diagnosis – Pathology 10:00-12:00 THE YEAR IN REVIEW
Diagnostic Pathology P5-11
Moderator: C. Kent Osborne, MD
Detection and Diagnosis – Other P5-12
Baylor College of Medicine
Prognosis/Response Predictions Houston, TX
Response Predictions – II P5-13
Advances in Basic Breast Cancer Research
Prognostic and Predictive Factors – Other P5-14
Kornelia Polyak, MD, PhD
Psychosocial, Quality of Life, and Educational Aspects Dana-Farber Cancer Institute
Doctor-Patient Communication P5-15 Boston, MA
Education P5-16
Transitional Breast Cancer Research
Psychosocial, Quality of Life,
Andrea Richardson, MD, PhD
and Educational Aspects – Other P5-17
Dana-Farber Cancer Institute
Treatment - Chemotherapy Boston, MA
Adjuvant Chemotherapy P5-18
TBA
Chemotherapy in Advanced Disease P5-19
Nancy E. Davidson, MD
Toxicities and Management P5-20
University of Pittsburgh Cancer Institute
Treatment - Trial Resources etc. Pittsburgh, PA
Tissue and Data Banks P5-21
Challenges and Successes: Treatment of Metastatic Breast Cancer
Clinical Trials Design and Management P5-22
2011
Treatment – Other P5-23
Hope S. Rugo, MD
5:00-7:00 POSTER SESSION ONGOING TRIALS 3 – Exhibit Halls A-B University of California San Francisco
New Agents OT3-01-01 San Francisco, CA
Other OT3-02-01 12:00 ADJOURNMENT

10
 history

The First Annual San Antonio Breast Cancer Symposium was sponsorship of the Symposium. In 1992, C. Kent Osborne, MD
held November 11, 1978 during Breast Cancer Awareness Week, became Co-Director of the symposium upon the death of William
and was part of an intensive 3-year outreach program of public L. McGuire, MD. In 1999, C. Kent Osborne, MD, Co-Director of the
and professional education designed to significantly reduce the symposium left UTHSCSA and opened the Breast Center at Baylor
death rate caused by breast cancer in San Antonio and surrounding College of Medicine. In 2005, Baylor College of Medicine became a
counties. It was sponsored by Cancer Therapy and Research joint sponsor of the symposium. In 2008 the American Association
Center (CTRC) and the American Cancer Society, Texas Division, for Cancer Research became a joint sponsor of the symposium.
in conjunction with The University of Texas Health Science Center Through the efforts of UTHSCSA, AACR and BCM, the program
at San Antonio (UTHSCSA) and the Bexar County Medical Society. attracts more thought-leaders and high-quality proffered papers in
That all-day course for physicians and surgeons was organized and basic and translational breast cancer research as well as increasing
co-directed by Charles A. Coltman, Jr., MD and William L. McGuire, the participation of young investigators by providing superior
MD, both Professors of Medicine at UTHSCSA. It featured invited education and training opportunities for the next generation of
presentations by a panel of internationally known specialists and breast cancer researchers.
was attended by 141 physicians and surgeons from a 5-state area.
Three years later, in 1981, the meeting was expanded to two days, a The driving force behind the collaboration is the shared mission
call for abstracts was distributed worldwide, and proffered papers for of the partners to advance progress against breast cancer. By
slide and poster presentations were incorporated into the program, combining their respective strengths, the partnership will produce
thereby broadening its scope to both attract and draw from a larger, a scientific meeting that encompasses the full spectrum of breast
international base. Renowned experts gave formal plenary lectures, cancer research, facilitating the rapid translation of new knowledge
and accepted abstracts were published for the first time in the into better care for breast cancer patients.
peer-reviewed journal Breast Cancer Research and Treatment. Case In 2010 Peter M. Ravdin, MD, PhD, Director of the Breast Cancer
discussion lunches offered opportunity for discussion of complex Program at the Cancer Therapy & Research Center at UT Health
clinical problems in the management of primary and metastatic Science Center assumed the role of Co-Director of the symposium
disease, by a panel of physicians from different disciplines. upon the retirement of Charles A. Coltman, Jr, MD. Dr. Coltman
Although some modifications have been made in the format, such remains Co-Director, ex-officio.
as incorporating pre-symposium educational sessions, Year In In 2011 Carlos L. Arteaga, Professor of medicine and Cancer
Review and lunchtime forums the overall format remains very much Biology, Interim Director, Division of Hematology-Oncology,
the same. This reflects the objective of the Symposium, which is to Director, Breast Cancer Program, Vanderbilt-Ingram Cancer Center,
provide state-of-the-art information on the experimental biology, Vanderbilt University was appointed Co-Director of the symposium
etiology, prevention, diagnosis, and therapy of breast cancer representing American Association for Cancer Research.
and premalignant breast disease, to an international audience of
academic and private physicians and researchers. The UT Health Science Center San Antonio School of Medicine,
through the Office of Continuing Medical Education, continues to
In 1990, CTRC and UTHSCSA formally entered into a collaboration be the provider of CME sponsorship for this premier breast cancer
known as the San Antonio Cancer Institute (an NCI designated symposium.
Comprehensive Cancer Center), which in 1995 assumed direct

11
 symposium information

FOR CURRENT INFORMATION, ON-LINE REGISTRATION AND HOUSING PLEASE REFER TO OUR WEBSITE http://www.sabcs.org

Symposium Objective Exhibit Hall C

This symposium is designed to provide state-of-the-art information Exhibits, Product Theatre, Loading dock (for exhibitors), Internet
on the experimental biology, etiology, prevention, diagnosis, and Café & Wi-Fi Lounge, First Aid station, Dining: Continental
therapy of breast cancer and premalignant breast disease to an breakfast (Wednesday and Saturday), concessions
international audience of academic and private physicians and Exhibit Hall D
researchers. General Sessions, Award Lectures, Mini-Symposia, Special Reports,
Plenary Lectures
Structure
Ballroom A
The scientific program consists of formal lectures by experts in clinical
Clinical Science Forum, Case Discussions, Poster Discussions
and basic research, selected slide and poster presentations, forums
and case discussions. The official language of the symposium is Ballroom B
English. Simultaneous translation is not provided. Mini-Symposia, Career Development Forum, Basic Science Forums,
Poster Discussions
Accreditation Concourse (2nd) level
UT Health Science Center San Antonio School of Medicine is accredited Park View Atrium: Press Room, Speaker lounge
by the Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians. Smoke-Free Environment
UT Health Science Center School of Medicine designates this The Henry B. Gonzalez Convention Center is a non-smoking facility.
educational activity for a maximum of 48.25 AMA PRA Category 1 No smoking is allowed anywhere in the building.
CreditsTM. Physicians should only claim credit commensurate with the
Climate & Comfort
extent of their participation in the activity.
The average temperature in San Antonio in December ranges from
Badges Required 45°F to 65°F (7°C to 18°C). Remember that meeting rooms are usually
Past and current events have heightened security awareness around kept quite cool, so dress accordingly. For such a large audience, it is
the world. Although no one can predict world events, incidents or necessary to maintain a lower temperature than is comfortable for
situations, we are working to help ensure a safe and a successful everyone.
Symposium. To this end, we will require attendees to wear the
Food & Beverages
Symposium Name Badge to ALL Symposium activities (sessions,
exhibits, etc.) at the convention center. Continental breakfast is provided free of charge. Lunch options can
be purchased onsite at the Food Court and concession stands. Hors
Thank you for your cooperation. d’oeuvres & non alcoholic beverages at evening poster sessions are
provided free of charge. There will be a cash bar at the evening poster
Location
sessions.
The symposium takes place at:
Henry B. Gonzalez Convention Center Exhibit Hours
200 E. Market St. Wednesday, December 7, 2011 11:00 AM – 5:00 PM
San Antonio, TX 78205 Thursday, December 8, 2011 11:00 AM – 5:00 PM
The main entrance to the symposium is located on street level Friday, December 9, 2011 11:00 AM – 5:00 PM
across Market St. from the Marriott Riverwalk. Exhibits will be featured in Exhibit Hall C.
Symposium events & services are located on two levels of the
convention center.
Street (1st) level (Bridge Hall, Exhibit Halls A, B, C & D,
Ballrooms A & B)
Entrance
Coat check, baggage check, First Aid station
Bridge Hall
Registration, Housing, Information & Message Center, Poster
pickup
Exhibit Halls A & B
Poster Sessions, Poster Reprints, Continental Breakfasts (Thursday-
Friday), Receptions (Wednesday-Friday), Food Court, Grab & Go
lunch concession

12
 symposium information

Registration Highlights Group Registration

Everyone must register. Information is available on the symposium website (www.sabcs.org),
Discounted rates are available through October 31. or refer to page 23 of this booklet. Group Registrations must be received
You may register online at www.sabcs.org or download and by November 18.
print out a registration form in PDF format, until November 18.
After that date, you must register on site in Bridge Hall at the PRESS REGISTRATION
Henry B. Gonzalez Convention Center. The symposium provides complimentary registration to professional
If your pre-registration is postmarked or faxed after the cutoff journalists representing media organizations for the express purpose
date, it will not be processed and you must register on site. of gathering news and information to produce editorial coverage of
SABCS has unlimited attendance and preregistration is not the meeting.
required. Valid credentials are required of every journalist and PIO in order
Registration will be CLOSED from November 19 through to complete registration. These credentials include an official press
December 5. identification (business card, press pass, etc) and two bylined articles
Registration will resume on site at noon on December 6. (or a copy of the masthead if articles are not bylined), or a letter of
All payments must be in US currency, and payment must assignment. For further information visit our website at www.sabcs.
accompany registration. org/Media/Index.asp. Please fax the media registration form on page
Symposium badges will be mailed to pre-registrants prior to the 28 along with these valid credentials to Natalie Poole, Department of
symposium. Communications and Public Relations, American Association for
All participants receive their symposium materials and badge Cancer Research, at 215-440-9319. For further information, please call
holders at SABCS registration. 267-646-0619 or e-mail [email protected].
Registration Category Until October 31 / After October 31 Spouse/Guest Registration
Regular Registration..........................................................................$425 / $575 One spouse/guest registration can be included with each regular
Regular Registration: AACR members
with member ID............................................................................$375 / $525 registration. Please note that spouse/guest registration includes
UTHSCSA & BCM staff & faculty access ONLY to exhibits, does not include symposium materials, and
With valid ID....................................................................................$375 / $525 is not valid for CME credits.
Postdoctoral MD in training............................................................ $90 / $100
Postdoctoral PhD in training........................................................... $90 / $100 ID Required for Onsite Badge Pick Up
Patient Advocate/Survivor............................................................... $90 / $100 For security purposes, all attendees picking up their badges onsite
Press.............................................................................................................................$0 must present a photo ID in order to receive their badge. Please be sure
Student.......................................................................................................................$0 to bring your photo ID with you to the Henry B. Gonzalez Convention
Spouse/Guest of Registrants.............................................................................$0 Center.

Special Assistance On Site Registration Hours

If you require special assistance, please ccontact the symposium Tuesday, Dec 6 12:00 PM – 7:30 PM
office at 210-450-1550 or [email protected]. Wednesday, Dec 7 7:00 AM – 5:15 PM
Thursday, Dec 8 6:45 AM – 5:15 PM
Exhibitor Registration Friday, Dec 9 6:45 AM – 5:15 PM
All Exhibitors must check in at the Exhibitor registration counter. All Saturday, Dec 10 7:00 AM – 9:00 AM
exhibitors and staff must register. No one will be allowed on the floor
without a badge.
On-Site Check-In
Please refer to Support & Exhibits Information on the symposium
SABCS encourages all attendees to take advantage of early On Site
website (www.sabcs.org) for information regarding registrations for
Registration on Tuesday, December 6, 12:00 pm – 7:30 pm. All
exhibit staff. All other registrants will pay the regular registration fee,
registration counters will be open.
subject to the preregistration deadline of November 18.
Registration will be located in Bridge Hall at the Henry B. Gonzalez
Convention Center.
Exhibitor Registration Hours
Monday, Dec 5 1:00 PM – 5:00 PM
All those who registered before the deadline and have their badge,
Tuesday, Dec 6 9:00 AM – 7:30 PM should proceed to the Pre-Registered counters in Bridge Hall to
Wednesday, Dec 7 7:00 AM – 5:15 PM receive meeting materials and a badge holder. Badges are required in
Thursday, Dec 8 6:45 AM – 5:15 PM order to pick up meeting materials.
Friday, Dec 9 6:45 AM – 5:15 PM Individuals who missed the pre-registration deadline must register on
site at the On-Site Registration counters in Bridge Hall.

13
 symposium information

Cancellations And Refunds Symposium Shuttle Buses

Cancellations received on or before November 18, 2011 will SABCS provides free shuttle bus transportation between symposium
be refunded less the following processing fees: $75.00 Regular hotels and the convention center December 6-10, 2011.
Registration, $20.00 Postdoctoral MD or PhD in training, $20.00 Shuttle buses will travel frequently between symposium hotels
Patient Advocate. Cancellations received after November 18, 2011 and the convention center.
are non-refundable. If canceling your registration will also result in This service is free.
cancellation of your slide or poster presentation, please so state when Buses will drop off and pick up at the Market Street Entrance of the
giving notice. Henry B. Gonzalez Convention Center.
Buses will only stop at the official symposium hotels.
Hotel Accommodations
A wheelchair accessible bus will be available during the listed days
The meeting site for the 2011 Symposium is the Henry B. Gonzalez and times. It is necessary to make reservations for this service by
Convention Center, 200 E. Market Street, located downtown on calling Circa Texas at 210-394-0607. Please call 24 hours in
the scenic Riverwalk, and is within easy walking distance of many advance to make your reservation at your specific hotel.
restaurants and other stores. For current schedule and any additional stops which may be
The Marriott Rivercenter remains our headquarters hotel. Additional added, please visit www.sabcs.org. Shuttle routes and times are
rooms at special SABCS rates have also been obtained at more than available on the symposium website at www.sabcs.org.
27 other hotels nearby, and all requests will be processed by SABCS SABCS does not provide transportation from the airport to hotels.
Housing Bureau. Information and online reservations for both groups
and individuals are available on the SABCS website. Children
Due to liability restrictions and concerns, children under eighteen
You may also refer to pages 17-20 of this book for information and
years of age may not participate in any part of this conference.
forms for reservations by fax or mail.
Photography
Transportation
Still photography is allowed for personal use only. Publication of any
Discounted Travel
photos is prohibited without the express permission of SABCS. In order
Lufthansa German Airlines offers a comprehensive global route to take photos for publication journalists must be registered as press.
network linking major cities around the world. As an airline partner,
Lufthansa offers special prices and conditions to participants, visitors, Video cameras are granted access to the Registration area and press
exhibitors and invited guests as well as employees of the Contracting room. Access to other areas of the Symposium requires pre-approval
Partner and their travel companions. from SABCS. Still cameras are granted access to all areas of the
Symposium. “Flash” photography is not allowed in order to minimize
To make a reservation, please visit www.lufthansa.com/event- disturbance to attendees. Camera crews filming in meeting areas other
booking_en and enter the access code USZUEL in the “Access to than the press room or news briefing room must be accompanied at all
Event Booking” area. This will open an online booking platform that times by a press room staff member.
will automatically calculate the discount offered or provide you with
an even better offer if another promotional fare is available. Photographers or camera crews hired by the aforementioned
representatives or exhibitors must obtain permission from press room
NOTE: Pop-ups must be enabled otherwise the booking platform staff to conduct any on-site photo or video shoots during the Symposium.
window will not open.
These promotional fares are also available through your IATA / Cell Phones
ARC travel agent. Travel agents can obtain ticketing instructions by Ringing phones and conversations make it difficult for your colleagues
sending an email to [email protected] and providing the to fully benefit from SABCS sessions. To provide an environment
access code as a reference. conducive to education, we ask that you observe the following
courtesies while inside the symposium:
Transportation From Airport To Hotel
Please turn your cellular phone off or switch to a silent mode.
GO Airport Shuttle, San Antonio Airport’s official shuttle service,
If receiving a call, please immediately put the call on hold and
has shuttles departing to and from downtown approximately
move to a foyer or similar area to use your phone.
every 15 minutes from 7:00 AM – 1:30 AM daily. For 24 hour
reservations and information, call 210-281-9900, or go online to If making a call, we ask that you move to a foyer or similar area
www.goairportshuttle.com. to initiate your call.

Shuttle tickets are sold at the baggage claim area, at Terminal 1 and Internet Café
Terminal 2 for $18.00 each. The SABCS will operate an Internet Café with approximately 30
Taxi fare is approximately $27.00. As many as 4 people may ride for computers for internet and e-mail access located in Exhibit Hall C.
the price of 1. SABCS does not provide transportation from the airport
Wireless internet access will be available in the wi-fi lounge next to the
to the meeting.
Internet Café. Connection setting information and a support specialist
will be available for assistance.

14
 symposium information

Literature Displays Slides from the symposium will be available to view by attendees
Literature racks will be available for non-profit organizations only for after the presentation. Select slides will be downloadable, author
posting of brochures, which must not exceed 8½x11 inches. Please permitting. Presentations are updated twice daily during the
contact the Symposium office at [email protected] for instructions. symposium.
An online, searchable version of the posters will be posted on line
information Boards for attendees to view during the symposium, author permitting.
Information boards will be located in Bridge Hall. Please contact the Selected oral presentations, including slides, will be available to
Symposium office at [email protected] for instructions. attendees within 48 hours after the symposium. All oral
presentations for which the authors have given permission will be
Proof Of Attendance posted in a fully produced webcast approximately 8 weeks
A statement verifying your attendance at the 2011 Symposium will be following the symposium.
in the symposium information packet in your tote bag. NOTE: This is 2011 SABCS abstracts, posters, slides, and webcast of oral
not a CME certificate. presentations will be made available online to non-attendees
January 1, 2012 .
San Antonio Sights At this time, SABCS plans to keep all of the above available on line
Although SABCS does not sponsor any recreational activities, visitors for 3 years.
to the city may obtain such information from the website of San
Antonio Convention and Visitors Bureau (www.sanantoniocvb. SABCS MOBILE APP
com). SABCS custom mobile app works across all smartphone platforms.
(Full service will be available on iPhone and Android devices; limited
Dining in San Antonio service on others.)
Creative Dining & Entertainment staff will recommend and make your
Downloadable App allow SABCS attendees instant, constantly
individual and/or group reservations at San Antonio’s most enjoyable
updated, and relevant access to:
restaurants and/or catering venues! The staff can also help you arrange
your rental car, golf tee time, other entertainment and relaxation Searchable abstract database that links to sessions.
needs. Their service, is free, and is available now either by phone Sessions can be stored as an individual itinerary builder.
210-632-1825, fax 210-468-0674 or e-mail lori@creativedining. Searchable Exhibitor Guide – by alpha, category, designation.
net. Staff will also be available onsite during the symposium in West Top News
Registration during the following hours: Local Weather
Tuesday, Dec. 6...................................................................... 12:00 PM – 8:00 PM In addition, SABCS text alerts are available if you desire.
Wednesday, Dec. 7..............................................................10:30 AM – 8:00 PM Download instructions can be found at www.sabcs.org in October.
Thursday, Dec. 8....................................................................10:30 AM – 7:30 PM
Friday, Dec. 9..........................................................................10:30 AM – 7:30 PM Newsletter
A daily newsletter featuring highlights of the symposium, late breaking
important Dates 2011
& revised abstracts, schedule changes and other news is published
Pre-registration Discount Deadline.................................... October 31, 2011 during the symposium. It is distributed on site and posted at www.
Pre-registration Deadline................................................... November 18, 2011 sabcs.org.
Hotel Reservation Deadline.............................................. November 18, 2011
Registration Cancellation Deadline............................... November 18, 2011 Contact Information
Career Development Forum Rich Markow, Director, Symposia
Registration Deadline................................................. November 18, 2011 Cancer Therapy & Research Center at UT Health Science Center
Onsite Registration Opens....................................................December 6, 2011 7979 Wurzbach Road, MC 8224
Symposium Begins..................................................................December 6, 2011 San Antonio, TX 78229 USA
Symposium Ends....................................................................December 10, 2011 E-mail: [email protected]
Phone: 210-450-1550 FAX: 210-450-1560
SABCS ON-LINE
Symposium website: www.sabcs.org
Each SABCS attendee will receive a log-in & password which will
allow access to 2011 SABCS abstracts, posters, slides, and webcast
of oral presentations online.
Future Symposium Meeting Dates
Abstracts online, searchable version of the SABCS abstracts will be
available to attendees during the symposium. Abstracts will be December 4-8, 2012 35th Annual SABCS
posted on the day of presentation. Check our website www.sabcs. December 10-14, 2013 36th Annual SABCS
org. These abstracts will also be published in the symposium’s December 9-13, 2014 37th Annual SABCS
abstract book, a special supplement to the AACR journal Cancer
Research.

15
 committees

Executive Committee Stephen Gottschalk, Baylor College of Medicine, Houston, TX

Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Joe Gray, Lawrence Berkeley National Lab, Berkeley, CA
Nashville, TN M. Carolina Gutierrez, Baylor College of Medicine, Houston, TX
Gary C. Chamness, Baylor College of Medicine, Houston, TX Jay R. Harris, Brigham and Women’s Hospital, Boston, MA
Suzanne A.W. Fuqua, Baylor College of Medicine, Houston, TX Daniel F. Hayes, University of Michigan Cancer Comprehensive Center,
Ismail Jatoi, UT Health Science Center, San Antonio, TX Ann Arbor, MI
Margaret Foti, American Association for Cancer Research, Philadelphia, PA Dawn Hershman, Columbia University Medical Center, New York, NY
C. Kent Osborne, Dan L. Duncan Cancer Center, Baylor College of Bruce Hillner, Virginia Commonwealth University, Richmond, VA
Medicine, Houston, TX Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center,
Peter M. Ravdin, UT Health Science Center, San Antonio, TX Houston, TX
Saraswati Sukumar, Johns Hopkins Oncology Center, Baltimore, MD Tim Hui-Ming Huang, Ohio State University, Columbus, OH
Ian Thompson, UT Health Science Center, San Antonio, TX Clifford Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY
Kelly Hunt, University of Texas MD Anderson Cancer Center, Houston, TX
Program Planning Committee James Ingle, Mayo Clinic College of Medicine, Rochester, MN
Carlos L. Arteaga (Co-Chair), Vanderbilt-Ingram Cancer Center, Vanderbilt Ismail Jatoi, UT Health Science Center San Antonio, San Antonio, TX
University, Nashville, TN Maria L. Jibaja-Weiss, Baylor College of Medicine, Houston, TX
José Baselga, Massachusetts General Hospital, Boston, MA Seema Khan, Northwestern University, Chicago, IL
Lisa Carey, University of North Carolina, Chapel Hill, NC Tari King, Memorial Sloan-Kettering Cancer Center, New York, NY
Gary C. Chamness, Baylor College of Medicine, Houston, TX Rakesh Kumar, The George Washington University Medical Center,
Richard Crownover, UT Health Science Center, San Antonio, TX Washington, DC
Margaret Foti, American Association for Cancer Research, Philadelphia, PA Charlotte Kuperwasser, Tufts University School of Medicine, Boston, MA
Suzanne A.W. Fuqua, Baylor College of Medicine, Houston, TX Adrian Lee, University of Pittsburgh Cancer Institute, Pittsburgh, PA
Judy Garber, Dana-Farber Cancer Institute, Boston, MA Michael T. Lewis, Baylor College of Medicine, Houston, TX
Luca Gianni, Istituto Nazionale Tumori, Milano, Italy Rong Li, UT Health Science Center San Antonio, San Antonio, TX
Susan G. Hilsenbeck, Baylor College of Medicine, Houston, TX Yi Li, Baylor College of Medicine, Houston, TX
Ismail Jatoi, UT Health Science Center, San Antonio, TX Jafi Lipson, Stanford University School of Medicine, Stanford, CA
Rong Li, UT Health Science Center, San Antonio, TX Anthony Lucci, University of Texas MD Anderson Cancer Center,
Yi Li, Baylor College of Medicine, Houston, TX Houston, TX
Susan Mooberry, UT Health Science Center, San Antonio, TX David A. Mankoff, University of Washington Medical Center, Seattle, WA
C. Kent Osborne (Co-Chair), Dan L. Duncan Cancer Center, Baylor College Kathy D. Miller, Indiana University, Indianapolis, IN
of Medicine, Houston, TX Mark Moasser, University of California San Francisco, San Francisco, CA
Charles M. Perou, University of North Carolina, Chapel Hill, NC Pamela Munster, University of California San Francisco, San Francisco, CA
Susan Rafte, Pink Ribbons Project, Houston, TX Soonmyung Paik, NSABP Foundation, Inc., Pittsburgh, PA
Amelie Ramirez, UT Health Science Center, San Antonio, TX Klaus Pantel, University Medical Center Hamburg-Eppendorf, Hamburg,
Peter M. Ravdin (Co-Chair), UT Health Science Center, San Antonio, TX GERMANY
Andrea Richardson, Brigham and Women’s Hospital, Boston, MA Edith Perez, Mayo Clinic, Jacksonville, FL
Mothaffar Rimawi, Baylor College of Medicine, Houston, TX Charles M. Perou, University of North Carolina, Chapel Hill, NC
Rachel Schiff, Baylor College of Medicine, Houston, TX Martine Piccart, Jules Bordet Institute, Brussels, BELGIUM
Sandi Stanford, Alamo Breast Cancer Foundation, San Antonio, TX Lori J. Pierce, University of Michigan Medical School, Ann Arbor, MI
Saraswati Sukumar, Johns Hopkins Oncology Center, Baltimore, MD Lajos Pusztai, University of Texas MD Anderson Cancer Center,
Trey Westbrook, Baylor College of Medicine, Houston, TX Houston, TX
Eric Winer, Dana-Farber Cancer Institute, Boston, MA Amelie G. Ramirez, UT Health Science Center, San Antonio, TX
Abstract Review Committee Peter M. Ravdin, UT Health Science Center, San Antonio, TX
Kathy Albain, Loyola University Health Center, Maywood, IL Abram Recht, Beth Israel Deaconess Medical Center, Boston, MA
D. Craig Allred, Washington University School of Medicine, St. Louis, MO Andrea Richardson, Dana-Farber Cancer Institute, Boston, MA
Carlos L. Arteaga, Vanderbilt-Ingram Cancer Ctr., Nashville, TN Hope S. Rugo, University of California San Francisco, San Francisco, CA
José Baselga, Massachusetts General Hospital, Boston, MA Rachel Schiff, Baylor College of Medicine, Houston, TX
Christopher Benz, Buck Institute for Age Research, Novato, CA Emily Sedgwick, Baylor College of Medicine, Houston, TX
Kimberly Blackwell, Duke University Comprehensive Cancer Center, Dennis J. Slamon, University California, Los Angeles, CA
Durham, NC George W. Sledge, Jr, Indiana University Simon Cancer Center,
Melissa Bondy, University of Texas MD Anderson Cancer Center, Houston, TX Indianapolis, IN
Powel Brown, University of Texas MD Anderson Cancer Center, Houston, TX Ian Smith, Royal Marsden Hospital, London, UNITED KINGDOM
Eric Chang, Baylor College of Medicine, Houston, TX Lawrence J. Solin, Albert Einstein Medical Center, Philadelphia, PA
Rowan Chlebowski, Los Angeles BioMed Research Institute, Torrance, CA Christos Sotiriou, Institute Jules Bordet, Brussels, BELGIUM
Massimo Cristofanilli, Fox Chase Cancer Center, Philadelphia, PA Patricia S. Steeg, National Cancer Institute, Bethesda, MD
Richard L. Crownover, UT Health Science Center, San Antonio, TX Sandra M. Swain, Washington Hospital Center, Washington, DC
Mitchell Dowsett, Royal Marsden Hospital NHS Trust, London, Laura J. van’t Veer, University of California, San Francisco, CA
UNITED KINGDOM Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA
Carol Fabian, University of Kansas Medical Center, Westwood, KS Antonio Wolff, Johns Hopkins Kimmel Cancer Center, Baltimore, MD
Suzanne A.W. Fuqua, Baylor College of Medicine, Houston, TX Douglas Yee, University of Minnesota, Minneapolis, MN
Judy E. Garber, Dana-Farber Cancer Institute, Boston, MA I-Tien Yeh, UT Health Science Center San Antonio, San Antonio, TX
Stefan Gluck, Univesity of Miami, Miami, FL Richard Zellars, Johns Hopkins University, Baltimore, MD
Matthew Goetz, Mayo Clinic College of Medicine, Rochester, MN
Ana Maria Gonzalez-Angulo, UT M. D. Anderson Cancer Center, Houston, TX
Paul Goss, Massachusetts General Hospital, Boston, MA
16
 Pe
ks
SAN ANTONIO

ull
Ba

e
How
on

dro

ou
ltim
S t

gh
cy

ore
t

St
St Hotel map & Information
uin i v er

Av
St
oR

Ri
lid Q

e
ch
Jo
St ne

om

i
en

ton
t sA
md

d
sS ve

An
Ca

St
lla
Da

San
10
35 t th
aS t St
st sS
ug
u ry'

Se
BAPTIST A a
.M

ym

9t
MEMORIAL
St

h
ou
HOSPITAL

St
rS

Le
8t
h 37

xin
t
t B St
ry S

gto
sbu
Galitzen St
o e nue Br

nS
g e oo
Kin

ay
Av kl
Main Ave

t
MUNICIPAL

dw
yn

Na
6t Av

oa
Giraud St AUDITORIUM h

va
St e

Br
rr o

St
o
Taylor St
St

m
M

a
cC
Convent St E

Al
e

ul
nu

lo
Martin St e

u
Av

4t

gh
h
Burn

Av
St
Jefferson St
b

e
ISTUS Pecan St

3r
TA Salinas St
St. Mary's St

d
A Salinas
St

St
Soledad St
Flores Ave

DICAL St Nola
Santa Rosa

Travis St

Chestnut St
TER
y St

Austin St
Navarro St

m
m ha
St

f z # n n
g Bo

Elm St
Cameron

p xHi Daws
Alamo St
St ous
l College THE ton
Alamo Pl
St
c a w ALAMO
ET SPANISH
CITY r
Crockett St
RE GOVERNOR'S HALL
Losoya St

Crocke
tt St
PALACE v Co
d mm erce
St k Crock
Laredo St

SAN RIVERCENTER s ett S

FERNANDO MALL
St

St
CATHEDRAL *
sa

t
Mark Bowie
Pre

et St
Vill j u
ita Com
St h merc
Gra e St
Ave

ham CONVENTION
St
Nuev
CENTER
Main

Du
Dwyer St

ran a St AMTRA
go DEPOT
t. Mary's t

37
S

Blv Gu
d
Alamo St

llbe
au
St TOWER OF THE
q AMERICAS
S

Montan
Ave

Bo
res

Downtown San Antonio

Flo

ie
Pres

ALAMOD
St

Ars INSTITUTE OF G
a St

ena
l St Free Shuttle Bus Lav arfie TEXAN CULTURES
St

KING WILLIAM Re acaDecember ld

on

Shuttle buses will operate continuously December 6 through St 10 between

er
io Riv

gt

DISTRICT fu St
g
hin

official symposium hotels and the convention

Ba center io at no charge. V
rre St ict Du
as
nton

St

or ra
W

a ia ng
St

St
St
am

St
nA

o
mo
illi

Bl
n

17
Sa

iso

vd
W

Ala
ad
ng

M
Ki
 Symposium hotels & rates

Hotel Rates* Hotel Rates*

Hotels single/double Hotels single/double
A Courtyard by Marriott $196/$196 O Hotel Indigo San Antonio Riverwalk $172/$172
San Antonio Riverwalk View/Balcony Rooms 830 N St Mary’s St.
207 N. St. Mary’s $216/$216
P Hotel Valencia Riverwalk $225/$225
B Crowne Plaza San Antonio $176/$176 150 E. Houston St.
111 E. Pecan St.
Q Hyatt Place San Antonio/Riverwalk $206/$206
C Drury Inn and Suites $160/$160 601 S. St. Mary’s St.
201 N. St. Mary’s
R Hyatt Regency San Antonio $227/$227
D Drury Plaza $160/$160 123 Losoya St.
105 S. St. Mary’s
s La Quinta Inn & $149/$149
E El Tropicano Riverwalk Hotel $119/$119 Suites Convention Center
110 Lexington Ave. 303 Blum St.

F Embassy Suites $206/$206 t Marriott Rivercenter $226/$226

San Antonio Riverwalk 101 Bowie St.
125 E. Houston St.
u Marriott Riverwalk $226/$226
G Emily Morgan Hotel $172/$172 889 E. Market St.
705 E. Houston St.
v Mokara Hotel $373/$373
H Grand Hyatt San Antonio $235/$235 212 W. Crockett St.
600 E. Market St.
w Omni La Mansion del Rio Hotel
$225/$225
I Hampton Inn Downtown $118/$118 112 College St.
414 Bowie St.
x Residence Inn by Marriott – $162/$162
J Hilton Palacio del Rio $227/$227 Alamo Plaza/Downtown
200 S. Alamo St. 425 Bonham St.

K Historic Menger Hotel $165/$165 y The St. Anthony – $189/$189

204 Alamo Plaza A Wyndham Historic Hotel
300 E. Travis St.
l Holiday Inn Riverwalk $162/$162
217 N. St. Mary’s Z Sheraton Gunter Hotel $192/$192
205 E. Houston St.
m Home2Suites by Hilton $149/$149
San Antonio – Downtown # TownePlace Suites $156/$156
603 Navarro St. San Antonio Downtown
205 E. Houston St.
N Hotel Indigo at the Alamo $228/$228
105 N. Alamo Plaza * Westin Riverwalk Hotel $227/$227
420 W. Market St.
The Marriott Rivercenter – Riverwalk
is the official Headquarters Hotel of the Hotels are added throughout the year.
San Antonio Breast Cancer Symposium. Please visit www.sabcs.org (click on “Housing”)
for the most recent list.
*(exclusive of tax & meals)
Rates are subject to availability.

Call: 800-243-1206 (US) 312-527-7300 (INTERNATIONAL)

Get What You Want.
Fax: 888-726-9290 or 404-393-3172
Book Today. Online: www.sabcs.org Email: [email protected]

18
 Housing Instructions

For best availability and immediate confirmation, make your reservation via the symposium website www.sabcs.org.

Housing by OnPeak DEPOSITS

MAKING YOUR RESERVATION Reservations will be processed on a first come, first served basis
You can book your SABCS housing in one of 5 EASY WAYS: and a two night room rate plus tax advanced deposit by credit
card (expiration date valid through December 2011) check or
1. Online – www.sabcs.org wire transfer is required. Wire transfer information is provided on
The most efficient way to book specially discounted hotel Group/Agency Housing form and can be provided by request to
rooms is online, with real-time hotel reservation processing. [email protected] or by fax to 888-726-9290 or
5 Simple Steps 404-393-3172. Please note this form is required for sending
deposit funds via a wire transfer. All deposits for individual
Months/Year reservations are due when the initial reservation is made. All new
reservations, changes, substitutions and cancellations must be
made through OnPeak. Please refer to your hotel confirmation
for individual cancellation and deposit policies. Group/Agency
housing requests must be accompanied by a credit card with an
2. Email – [email protected] expiration date valid during the time of stay or a $410 per room
Please provide all the information required on the enclosed deposit (non-refundable after September 30, 2011) by check or
Housing Request Form or download the Housing Request wire transfer only.
Form from www.sabcs.org and send as an attachment. GROUP RESERVATIONS
3. Fax Room block requests are limited to a maximum of 50 rooms per
Return the housing form (or download a printable form group per hotel with the exception of the Grand Hyatt and the
from www.sabcs.org) to 888-726-9290 or 404-393-3172. Marriott Rivercenter where requests are limited to a maximum
Please note: Incomplete forms cannot be processed. of 100 rooms. To obtain a Group Housing Request form, please
4. Mail contact OnPeak at [email protected] or fax to
Return the housing form to: 888-726-9290 or 404-393-3172. You can also download and
SABCS Housing Bureau print a Group Housing Request form from www.sabcs.org. Please
c/o OnPeak be sure to note SABCS policies and deadline dates provided on
240 Peachtree Street, Suite 22-S-10 the Group/Agency Housing Form. Group Sub-Block Confirmation
Atlanta, Georgia 30303 letters will be sent to you by fax. Please be sure to note SABCS
policies and deadline dates provided in this letter. Included in
5. Phone the Sub-block Confirmation letter is a login registration form for
800-243-1206 (US & Canada) Online Room/Sub-block Management. Please complete the form
312-527-7300 (International) and return to OnPeak by fax to 888-726-9290 or 404-393-3172.
DEADLINES Group/Agency reservations require a credit card along with a
Individual: November 18, 2011 valid expiration date during the time of stay or an initial $410 per
Group Room Block Requests: room deposit by check or wire transfer. This deposit or credit card
Rooming list: September 30, 2011 information must accompany the housing request form before
Confirmation of Master Account/Credit Card any rooms will be held. A financial commitment to utilize 100%
Authorization: September 30, 2011 of the total room nights is required. Rooms may be released prior
All reductions after September 30, 2011 are non-refundable. to September 30, 2011, however all reductions after September
Group/Agency Block Reduction: September 30, 2011 30, 2011 are nonrefundable. Credit Card authorizations or
Last Day for Changes: November 9, 2011 establishment of a Master Account with the applicable hotels is
required by September 30, 2011. Please see the Group/Agency
Reserve your room at one of the official 2011 SABCS hotels while Request form for further information.
discounted hotel rooms are available. All housing reservations
must be completed by this deadline to receive discounted hotel Please note the following group reservations policies:
rates, so don’t delay! Book your housing today to secure one of • For group reservations from travel agencies and other service
your top hotel preferences. All rates are based on the number providers, an original, signed, Agent of Record letter must be
of people staying in room and are subject to 16.75% occupancy sent to OnPeak by the client. Only originals on client letterhead
tax (subject to change). Special requests cannot be guaranteed; are acceptable; no fax or email.
however, the hotels will do their best to honor all requests. Hotels • Group sub-blocks cannot be re-sold to third parties or sub-
will assign specific room types upon check in, based on availability. contractors. Companies who do so will be permanently barred
Reservations are accepted on a first come, first served basis. A 2 from participation in SABCS, and all authorized SABCS vendors
night room rate + tax advance deposit by credit card valid through and hotels will be notified of same. Re-sold rooms are subject
December 2011, check or wire transfer is required. to cancellation and no refund will be issued.
ACKNOWLEDGEMENTS • Units for suite parlors and each connecting bedroom must
An acknowledgement of your hotel reservation will be sent to you be deducted from the current room block. All suites must be
immediately via email upon completion of the online process or approved by SABCS.
within 72 hours for reservations received via phone, fax or mail.

19
 Housing Request Form
1 HOTEL SELECTION
2011 CTRC-AACR San Antonio Breast Cancer Symposium
Please list your top three hotel selections. If choices are not December 6-10, 2011
available, we reserve the right to choose a hotel for you based Henry B. Gonzalez Convention Center
upon availability. San Antonio, Texas
DEADLINE: November 18, 2011
1.
Rewards Number
2. Attending Symposium Attending Satellite Event
Rewards Number Please check either one or both items above.
3.
Rewards Number
5 EASY WAYS TO MAKE A HOTEL RESERVATION
Check here if you need an ADA accessible room and may
require assistance from hotel in event of an emergency. 1. Online at: www.sabcs.org
2. Email: [email protected]
2 ROOM INFORMATION
3. Mail: OnPeak
Please supply names of all persons to occupy room(s) 240 Peachtree Street, Suite 22-S-10
and type of room. If more than 2 rooms are required, please copy Atlanta, Georgia 30303
this form. IMPORTANT NOTE! For groups of 10 or more you 4. Fax: 888-726-9290 or 404-393-3172
must fill out the Group/Agency Hotel Request form found at
5. Phone: 800-243-1206 (US and Canada)
www.sabcs.org.
312-527-7300
Room #1:
Please note: Incomplete forms cannot be processed.
Single Double-1 bed Double-2 beds
Triple Smoking Non-smoking
Quad
MUST BE FILLED OUT
Room #2:
Single Double-1 bed Double-2 beds 4 CONFIRMATION
Triple Smoking Non-smoking
Quad You should expect to receive a confirmation within 72 hours if
Arrival Date (mm-dd-yy): / / faxing this form to OnPeak. If you do not, please contact OnPeak.
Departure Date (mm-dd-yy): / /
Send confirmation to: (Please print clearly)
3 DEPOSIT INFORMATION The following information is required for completion of reservation.
Payment Guarantee
No charges are incurred at the time of booking, however, a payment guarantee is
required to hold your reservation in the amount of two night’s stay at the confirmed Contact Name
hotel plus current tax of 16.75%, subject to change. The hotel will charge payment
to the credit card provided upon check-in. Please refer to your confirmation for full
details, which may vary per hotel. Company Name
Guarantee with Credit Card
Address 1
Card Number

Month Year VS MC AMX DS

Address 2 City
Name as it appears on the card

State Zip Country

Signature
My signature above authorizes the assigned hotel to charge my credit card for the deposit
amount of two night’s room and tax. Telephone Number, with country and city codes
Guarantee with Check
Company checks are accepted to reserve rooms but must accompany this form
and be received no later than November 18, 2011. Two nights room rate plus tax Fax Number, with country and city codes
(currently 16.75%, subject to change) will be required to guarantee the reservation..
Make checks payable to OnPeak, LLC. Mail to: 2011 CTRC-AACR San Antonio Breast
Cancer Symposium c/o onPeak, 350 N. Clark St, Suite 200, Chicago, IL 60654. Email
Deposit by Wire Transfer
Deposits can be applied by a Wire Transfer. Wire Transfer information is provided upon Housing reservations for the 2011 CTRC-AACR San Antonio
request to [email protected] or fax to 888-726-9290 or 404-393-3172. This is a Breast Cancer Symposium is open.
required form if you are sending funds by a wire transfer. Two nights room rate plus For best availability and immediate confirmation, make your
tax will be required to guarantee the reservation.
reservation via the symposium website www.sabcs.org.
Cancellation Policy Faxed housing requests will take 72 hours to process.
Individual cancellation 10 business days prior to arrival.

20
21
 registration instructions

OnPeak has been appointed the official registration company for the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.
Please complete the required registration forms and fax or mail information to OnPeak .

Registration Methods MEALS

Online registration: www.sabcs.org Lunch meal tickets for SABCS are not offered. Lunch options which
Everyone must register in order to attend. can be purchased onsite will be available at the Food Court and
COMPLETED REGISTRATION FORMS concession stands.
Fax: 888-298-9883 or 404-920-3258 (International) Continental breakfast, evening poster sessions, receptions &
If you register via fax, please DO NOT also mail a beverages are provided free of charge.
copy, as duplicate charges may occur. CONFIRMATION
Mail: SABCS Please provide an email address when you register, regardless of
c/o OnPeak registration method. It will be used to confirm your registration, to
240 Peachtree St., Suite 22-S10 send you the CME/Evaluation link, and to update you on any future
Atlanta, GA 30303 USA developments regarding the Symposium.
Online: www.sabcs.org OnPeak will send written confirmation within 10 days of receipt of
the completed registration information. If you do not receive your
SYMPOSIUM BADGES WILL BE MAILED TO PRE-REGISTRANTS
confirmation within this time frame you may contact onPeak by
PRIOR TO THE SYMPOSIUM. Upon arrival at the symposium,
telephone at 877-517-3040, fax to 888-298-9883 or 404-920-3258
please present your badge at the “PRE-REGISTERED” desk in the
(International), or email [email protected].
convention center (Bridge Hall) in order to receive symposium
materials and badge holder. Badges will be mailed in Fall 2011.

PAYMENT REGISTRATION QUESTIONS

Payment must be in U.S. Currency, and checks must be drawn on a Phone: 877-517-3040 (US & Canada)
U.S. bank. 678-553-7223 x2301 (International)

DEADLINES Fax: 888-298-9883 or 404-920-3258 (International)

Discounted pre-registration ends October 31. Email: [email protected]
Pre-registration ends November 18. Group Registrations
On site registration opens December 6. See page 23 for additional information.
CANCELLATION POLICY Spouse/GUEST Registrations
Please send written notice of cancellation by fax to 888-298-9883 or One spouse/guest registration can be included with each regular
404-920-3258 (International) or email sabcsreg@onpeakevents. registration. Please note that spouse/guest registration includes
com. access only to exhibits, does not include symposium materials,
Cancellations received on or before November 18 will be refunded and is not valid for CME credits.
less the following processing fees: Media Registration
$75 Regular Registration Valid credentials are required of every journalist in order to complete
$20 Postdoctoral MD or PhD in training registration. These credentials include an official press identification
$20 Patient Advocate (business card, press pass, etc) and two bylined articles (or a copy of
Cancellations received after November 18 are not refundable. the masthead if articles are not bylined), or a letter of assignment.
NAME CHANGE POLICY Please fax the media registration form along with these valid
Please send written notice of name changes by fax to 888-298-9883 credentials to Natalie Poole, Department of Communications and
or 404-920-3258 (International) or by email to Public Relations, American Association for Cancer Research, at 215-
[email protected]. 440-9319. For further information, please call 267-646-0619 or email
All name changes after November 18 will be processed on site. [email protected].

22
 group registration instructions

A minimum of 5 people is required for group registration. ON-SITE CHECK IN

Do not use Group Contact’s address, telephone, fax or email for A representative is required for your group.
individual members of your group. Complete information for If an on-site representative is not designated, group
all members of each group must be received to insure proper registration will not be accepted.
credentials, as well as CME login information and individual receipt The On-Site Group Representative is responsible for the pickup
of important post-symposium materials. This information must and distribution of symposium badges and materials to group
include each person’s: members.
• institution No credentials will be mailed to group registrants in advance of
• address the meeting.
• city Prior to the symposium, the Group Representative will be
• state or province, if applicable contacted by the symposium office to set an appointment for
• telephone Monday, December 5, or Tuesday, December 6. No appointments
• fax are available on any other dates. At that appointment the Group
• email Representative will pick up badges and materials for all group
REGISTRATION METHOD members and will also have the opportunity to address changes,
Online cancellations, etc, with symposium staff.
You can register and manage group members utilizing a CANCELLATION POLICY
special web registration system designed exclusively for group Please send written notice of cancellation by fax to 888-298-
registrations. 9883 or 404-920-3258 (International) or email sabcsgroupreg@
The group registration contact must register and apply for a group onpeakevents.com.
ID and password prior to registering any group members. Cancellations received on or before November 18 will be refunded
You may register as the contact via the web based Group Contact less the following processing fees:
Registration form at www.sabcs.org or by faxing a completed $75 Regular Registration
Group Registration Contact Form to the facsimile number $20 Postdoctoral MD or PhD in training
indicated on the form. $20 Patient Advocate
Within five (5) business days of receipt of the group contact Cancellations received after November 18 are not refundable.
information, you will be provided your group ID number and NAME CHANGE POLICY
password by return email. Please send written notice of name changes by fax to 888-298-
Once you have received your ID number and password, you will be 9883 or 404-920-3258 (International) or email sabcsgroupreg@
able to register and manage your group at www.sabcs.org. onpeakevents.com.
If you have any questions please email them to: All name changes after November 18 will be processed on site.
[email protected] COMPLETED REGISTRATION FORMS
SPREADSHEETS WILL NOT BE ACCEPTED. Fax: 888-298-9883 or 404-920-3258 (International)
Mail or Fax If you register via fax, please DO NOT also mail
a copy, as duplicate charges may occur.
Send the completed Group Registration Contact Form, as well as
an Individual Registration Form for each attendee you are booking Mail: SABCS
as part of your group. Group Contact must complete an Individual c/o OnPeak
Meeting Registration Form for each person on their group 240 Peachtree St., Suite 22-S10
registration list. Group Registrations will not be processed until all Atlanta, GA 30303 USA
Individual Registration Forms have been received. Online: www.sabcs.org
SPREADSHEETS WILL NOT BE ACCEPTED. Email Group Registration to:
[email protected]
CONFIRMATION
OnPeak will send all Group Contacts or individual group members
written confirmations within 10 days of receipt of the completed
registration information. If you do not receive your confirmations
within this time frame you may contact OnPeak by fax at 888-298-
9883 or 404-920-3258 (International) or email sabcsgroupreg@
onpeakevents.com
23
 Group Registration Contact Form
Group Registrations Deadline: November 18, 2011
2011 CTRC-AACR San Antonio Breast Cancer Symposium FOR OFFICE USE ONLY • Group ID Code

1 GROUP IDENTITY
Number of persons in the group (must have at least 5)
4 ON-SITE GROUP REPRESENTATIVE Cont.
Group’s Corporate Sponsor
2 REGISTRATION METHOD
Fax Number (country code + city or area code + number):
Online The group registration contact must register and apply for
a group ID and password prior to registering any group members.
Email Address (Either fax number or Email is required):
You may register as the contact via the web based Group Contact
Registration form at www.sabcs.org or by faxing a completed
Group Registration Contact Form to the facsimile number indicated 5 GROUP PAYMENT TYPE (No Purchase Orders)

on the form. Within five (5) business days of receipt of the group Check/Money Order/Draft.
contact information, you will be provided your group ID number (Make payable to UTHSCSA-CME#130471) Tax ID: 74-1586031
and password by return email. Once you have received your ID Wire Transfer, your bank to ours. Add $30 to total for transfer fees
number and password, you will be able to register and manage
your group at www.sabcs.org. SPREADSHEETS WILL NOT BE Instructions for wire transfer will be sent to you by email
ACCEPTED. after your registration is received by SABCS.
Fax or Mail Complete and fax or mail this form along with a
American Express Master Card Visa Discover
registration form for each group member to the fax number or
address listed below. If you fax the information, do not mail the
information or duplicate charges could occur. SPREADSHEETS Credit Card Number
WILL NOT BE ACCEPTED.
Expiration Date (MM/YY)
3 GROUP CONTACT INFORMATION
If Group Contact will attend the Symposium, he/she must register and pay Cardholder Name
along with other Group members.
Signature
Contact Name
6 SABCS Abstract Book
Each SABCS registrant will receive a log-in & password which will allow
Company or Agency Name
access to SABCS abstracts, slides & posters online. Printed abstract books
can be purchased for $30 when registering in advance or on site.
Address
7 REGISTRATION FEE
City State or Province Postal or ZIP Code Through October 31, 2011: $425
Effective November 1, 2011: $575
Abstract Book: $30 each
Country
Wire Transfer Fee $30 (if applicable)
TOTAL AMOUNT DUE $
Phone Number (country code + city or area code + number)
8 CONFIRMATIONS
Fax Number (country code + city or area code + number) Send registration confirmations to Group Contact to individuals

9 FAX OR MAIL OPTION (5-15 only)

Email Address (Either fax number or Email is required)
You must complete an Individual Meeting Registration Form for each
4 ON-SITE GROUP REPRESENTATIVE person on your list.
An on-site representative is required for your group. If an on-site FAX THIS FORM TO 888-298-9883 or 404-920-3258, or mail to:
representative is not designated, group registration will not be accepted. SABCS Group Registration
c/o OnPeak
Contact Name
240 Peachtree St., Suite 22-S10
Atlanta, GA 30303 USA
Company or Agency Name
CANCELLATIONS POLICY
Cancellations must be in writing and received by November 18.
Address
NAME CHANGES POLICY
Changes must be made in writing and received by November 18.
City State or Province Postal or ZIP Code After November 18, name changes must be made on-site.
CANCELLATION REFUNDS
Country Cancellations received on or before November 18 will be refunded less
a $75.00 Processing Fee. Registrations received after November 18 are
Phone Number (country code + city or area code + number) nonrefundable.
24
25
 Advance Registration Form FOR OFFICE USE ONLY • Group ID Code
2011 CTRC-AACR San Antonio Breast Cancer Symposium • December 6–10, 2011
COMPLETE ALL SECTIONS FULLY • ONE INDIVIDUAL PER FORM
CIRCLE ONE
Dr. Prof. Mr. LAST NAME FIRST NAME MI
Mrs. Ms. Miss

DEGREE(s) (or Equivalent)

MD DO PhD INSTITUTION, COMPANY, or ORGANIZATION NAME
PharmD RN Other
DEPARTMENT

ADDRESS 1

ADDRESS 2 CITY

STATE or PROVINCE COUNTRY (if not US)

ZIP OR POSTAL CODE TELEPHONE NUMBER, WITH COUNTRY & CITY CODES FAX NUMBER, WITH COUNTRY & CITY CODES

EMAIL ADDRESS (PLEASE NOTE: CME/Evaluations will be sent by email to the address provided)

Emergency Contact Name & Phone Number

SPOUSE–IF ATTENDING: One spouse registration can be included with each regular registration. Note: Spouse registration permits access to EXHIBITS ONLY and does not include symposium materials and is not valid for CME credits.
Spouse LAST NAME SPOUSE FIRST NAME MI
THIS PAGE MAY BE PHOTO COPIED

PRIMARY PROFESSIONAL FOCUS PRIMARY PROFESSIONAL OCCUPATION (Check ONE only):

(Check ONE only): Medical Practice/Clinical Research Basic Research Industry Other Profession
Medical Practice/Clinical Research 01 Medical Oncologist 08 Clinical Geneticist 20 Laboratory Scientist 30 Corporate Research 40 Patient Advocate
Basic Research 02 Surgical Oncologist 09 Oncology Nurse 21 Statistician 31 Marketing/Sales 41 Administrator
Epidemiology 03 Radiation Oncologist 10 Research Nurse 22 Epidemiologist 32 Industry Nurse 42 Other PR
Prevention 04 General Surgeon 11 Data Manager 23 Postdoctoral Fellow 33 Pharmaceutical Rep 43 Press/Media
Translational Research 05 Gynecologic Oncologist 12 Other Physician 24 Research Assistant 34 Industry PR 44 Medical Writer
Other 06 Pathologist 13 Other Nurse 25 Student 35 Other Industry 45 Pharmacist
07 Radiologist 46 Other Occupation

(Check One)
ADVANCE ON SITE SABCS Abstract Book: Each SABCS registrant will receive a log-in & password
REGISTRATION CATEGORY: before 10/31/2011 after 10/31/2011
which will allow access to SABCS abstracts, slides & posters online. Printed abstract
Regular Registration RRA $ 425 $575 books can be purchased for $30 when registering in advance or on site.
Regular Registration: AACR members CRA $ 375 $525
Total for Registration Fee. . . . . . . . . . . . . . . . . . . . . . $
AACR member ID:
Wire Transfer Fee $30 (if applicable). . . . . . . . . . . . $
Regular Registration: UTHSCSA & BCM staff & faculty ST $ 375 $525
(Valid ID required w/registration)
Postdoctoral MD in training Printed abstract book $30 . . . . . . . . . . . . . . . . . . . . . $
PMA $ 90 $100
Postdoctoral PhD in training PPA $ 90 $100 TOTAL AMOUNT DUE. . . . . . . . . . . . . . . . . . $
Payment must be in US Currency. • Checks must be drawn on US bank.
Press PS $ 0 $ 0
PAYMENT TYPE: (No Purchase Orders.)
Student (Valid ID required w/registration) SU $ 0 $ 0 Payment is being made by Group Contact.
Patient Advocate* PAA $ 90 $100 Check/Money Order/Draft.
(Must provide name of the organization you are representing)
(Make payable to UTHSCSA #130471)
Advocate Organization Wire Transfer, your bank to ours. Add $30 to the total for transfer fees.
*Contact Alamo Breast Cancer Foundation PO Box 780067, San Antonio TX 78278, for Advocate Program information
and possible financial assistance • Email [email protected] Instructions for wire transfer will be sent to you by Email after your
Are you part of an official Group Registration? No Yes registration is received by SABCS.

(Provide Group ID Code here.) AMEX MasterCard Visa Discover

REFUNDS: Cancellations received on or before November 18, 2011 will be Credit Card Number
refunded less processing fees. Cancellations received after November 18, 2011
are non-refundable. Exp Date (MM/YY)
Mail to: OR Fax to:
Cardholder Name
SABCS Registration c/o OnPeak 888-298-9883
240 Peachtree St. 22-S-10 or 1 404-920-3258
Signature
Atlanta, GA 30303 (International)
Pursuant to the Americans With Disability Act, I require specific aids or
Registration inquiries may be directed to: [email protected] services during my visit. Please contact SABCS with your needs to
or by phone 877-517-3040 (US & Canada) or 678-553-7223 x 2301 (International). [email protected].

26
27
 Advance
Advance Registration
Registration Form
Form –– Press/Media
Press/Media

2011 CTRC-AACR San Antonio Breast Cancer Symposium • December 6–10, 2011
COMPLETE ALL SECTIONS FULLY • ONE INDIVIDUAL PER FORM
Please submit this form with your credentials. CREDENTIALS ARE REQUIRED for approval of Press/Media registrations. For further
information contact Natalie Poole, American Association for Cancer Research, [email protected].
Credentials:
Press & media staff: Company Press ID and two bylined articles or a copy of the masthead.
Freelance: Signed letter of assignment on company letterhead.
Fax to:
Natalie Poole, American Association for Cancer Research, 215-440-9319
Mail to:
Natalie Poole
American Association for Cancer Research
615 Chestnut Street
17th Floor
Philadelphia, PA 19106

CIRCLE ONE
Dr. Prof. Mr. LAST NAME FIRST NAME MI
Mrs. Ms. Miss

INSTITUTION, COMPANY, or ORGANIZATION NAME

DEPARTMENT

ADDRESS 1

ADDRESS 2 CITY

STATE or PROVINCE COUNTRY (if not US)

ZIP OR POSTAL CODE TELEPHONE NUMBER, WITH COUNTRY & CITY CODES FAX NUMBER, WITH COUNTRY & CITY CODES

EMAIL ADDRESS

Pursuant to the Americans With Disability Act, I require specific aids or services during my visit. Please contact SABCS with your needs
to [email protected].
CANCELLATION
Please notify SABCS via fax c/o OnPeak at 888-298-9883 or email [email protected] if you must cancel your registration.
SABCS PRESSROOM
SABCS maintains a pressroom located on the concourse level of the convention center, directly upstairs from our sessions. Audio and video of speakers
and slides are transmitted to the pressroom. Facilities include photocopier, fax machine, and desk space with high-speed internet connection.
SABCS Abstract Book
Each SABCS registrant will receive a log-in & password which will allow access to SABCS abstracts, slides & posters online. Printed abstract books can be
purchased for $30 when registering in advance or on site.

Printed abstract book $30 . . . . . . . . . . . . . . . . . . . . . $ AMEX MasterCard Visa Discover

TOTAL AMOUNT DUE. . . . . . . . . . . . . . . . . . . . $ Credit Card Number

Payment must be in US Currency. • Checks must be drawn on US bank.
Exp Date (MM/YY)
PAYMENT TYPE: (No Purchase Orders.)
Payment is being made by Group Contact. Cardholder Name
Check/Money Order/Draft.
(Make payable to UTHSCSA #130471) Signature
Wire Transfer, your bank to ours. Add $30 to the total for transfer fees.
Instructions for wire transfer will be sent to you by email after your
registration is received by SABCS.

28
29
 Career development forum registration form
Career Development Forum:
A Networking Session for Young Investigators
Registration Deadline:
Wednesday, December 7, 2011 • 6:45 a.m.– 8:15 a.m November 18, 2011
Ballroom A, Henry B. Gonzalez Convention Center
San Antonio, TX
• The session is open to early-career scientists, defined as graduate students, postdoctoral or clinical fellows, or medical students
and residents, who are registered attendees of the SABCS.
• Space in the workshop is limited to 200 participants; registrations will be accepted on a first-come, first-served basis and is free
of charge.
Registration Form (all Fields Required)

FIRST/GIVEN NAME MIDDLE NAME LAST/FAMILY NAME

DEGREE TITLE/POSITION

DEPARTMENT

INSTITUTION

INSTITUTION ADDRESS 1

INSTITUTION ADDRESS 2 CITY

STATE or PROVINCE COUNTRY

ZIP OR POSTAL CODE TELEPHONE NUMBER, WITH COUNTRY & CITY CODES FAX NUMBER, WITH COUNTRY & CITY CODES

E-MAIL ADDRESS

Demographic Information
(Optional, for program development purposes only. Information will be kept confidential)

Gender: Male Female

Are you a clinician-scientist: Yes No
Race/Ethnicity: Caucasian/White
African-American/Black
Asian
Hispanic
Native Pacific Islander
Native American
Alaskan Native
Other

Please return to:

SABCS Fax 1 210-450-1560
[email protected]

30
 industry and agency support
(at press time)

We are proud to acknowledge the following for their contributions to and

generous support of our program (at press time). Exhibit Hours
Wednesday, December 7, 2011 11:00 AM – 5:00 PM
Premier Thursday, December 8, 2011 11:00 AM – 5:00 PM
Celgene Corporation Friday, December 9, 2011 11:00 AM – 5:00 PM
Genentech, A Member of the Roche Group Exhibits will be featured in Exhibit Hall C.

Angel
Amgen Exhibitor List (at press time)
Eisai, Inc. Agendia, Inc. Faxitron X-Ray LLC
Genomic Health, Inc. Alamo Breast Cancer Foundation FORCE: Facing Our Risk of Cancer
AlphaMed Press/The Oncologist Empowered
PATRON
Clarient, a GE Healthcare Company American Association for Cancer Genentech, A Member of the
Research (AACR) Roche Group
Major Supporter American Cancer Society Genomic Health, Inc.
AlphaMed Press/The Oncologist American Institute for Cancer GlaxoSmithKline
AstraZeneca Research Harborside Press
bioTheranostics Amgen HER2 Support Group
Celltrion Healthcare ARUP Laboratories HistoRx, Inc.
Novartis Oncology
AstraZeneca Hologic
Pfizer
Atossa Genetics and National ImpediMed, Inc
Contributors Reference Laboratory for
Lippincott Williams & Wilkins
Breast Health
Agendia, Inc. McKesson Specialty Care
Bristol-Myers Squibb Biocare Medical
Solutions/US Oncology
Eli Lilly and Company Biocept
Medcomp
GlaxoSmithKline BioMed Central
Metastatic Breast Cancer
Myriad Genetic Laboratories, Inc. bioTheranostics Network
Nanostring Technologies, Inc. Boehringer Ingelheim Myriad Genetic Laboratories, Inc.
Nektar Therapeutics Pharmaceuticals, Inc.
Pfizer NanoString Technologies, Inc.
Breast Cancer Action
National Accreditation Program
Donors Bristol-Myers Squibb for Breast Centers (NAPBC)
ARUP Laboratories Cancer Support Community National Breast Cancer Coalition
Biocare Medical Cancer Therapy & Research National Lymphedema Network,
Biocept Center Inc.
BioMed Central Care Wise Medical Products Novartis Oncology
Boehringer Ingelheim Pharmaceuticals, Inc. Caris Life Sciences Onyx Pharmaceuticals/Bayer
Caris Life Sciences Carl Zeiss Healthcare Pharmaceuticals
Carl Zeiss
Celgene Corporation PRIME Oncology
Clinical Oncology News
Compendia Bioscience Celltrion Healthcare SHARE: Self Help for Women
Clarient, a GE Healthcare with Breast or Ovarian Cancer
Elekta, Inc.
Endomagnetics Ltd Company Sharsheret
Faxitron X-Ray, LLC Clinical Oncology News Siemens Healthcare Diagnostics
HistoRx, Inc. Compendia Bioscience Susan G. Komen for the Cure®
Hologic Congressionally Directed US Labs/Genzyme Genetics
ImpediMed, Inc Medical Research Programs Varian Medical Systems
Lippincott Williams & Wilkins (CDMRP)
Vaxco Pharmaceuticals, Inc.
McKesson Specialty Care Solutions/US Oncology Dilon Diagnostics
Medcomp Ventana Medical Systems, Inc.
Eisai, Inc.
Onyx Pharmaceuticals/Bayer Healthcare Pharmaceuticals Veridex, LLC
Elekta, Inc.
US Labs/Genzyme Genetics Women in Cancer
Varian Medical Systems Eli Lilly and Company
Young Survival Coalition
Ventant Medical Systems, Inc. Elsevier
Veridex, LLC Endomagnetics Ltd

SABCS gratefully acknowledges Susan G. Komen for the Cure for generous support of AACR Outstanding Investigator
Award for Breast Cancer Research, CTRC-AACR San Antonio Breast Cancer Symposium Educational Sessions.
SABCS wishes to thank Avon Foundation for support of the
Avon Foundation-AACR International Scholar-In-Training Grants.
 Non-Profit Organization
U.S. Postage
PAID
Permit 1001
San Antonio, Texas

Cancer Therapy & Research Center at

UT Health Science Center San Antonio
7703 Floyd Curl Drive, MC 8224
San Antonio TX 78229

December 6–10, 2011

2011 CTRC-AACR San Antonio Breast Cancer Symposium
www.sabcs.org